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ABSTRACT 
BILLIG, H. ADENOSINE AND OVARIAN FUNCTION. Studies on adenosine as 
substrate and receptor agonist in the rat ovary, pages 1-46 
Department of Physiology, University of Göteborg, Box 33031, S-400 33 Göteborg, 
Sweden. 
Adenosine is an indispensable compound in cell energy metabolism, as precursor 
to cofactors, second messenger and nucleic acids. Adenosine is also an agonist to 
adenosine receptors. The adenosine receptor can either inhibit (A^) or stimulate 
(A2) adenylate cyclase. Alternatively, in some cells adenosine receptor activation is 
linked to other cellular events like inhibition of Ca^ + fluxes. 
In the present study the possible dual effects of adenosine as substrate and 
adenosine receptor agonist were investigated in rat granulosa cells, cumulus-oocyte 
complexes, luteal cells and ovarian membranes. 
Adenosine was taken up by isolated preovulatory granulosa and luteal cells from 
PMSG-treated immature rats but follicle stimulating hormone (FSH) decreased the 
uptake by granulosa cells. Adenosine, but not the non-metabolizable adenosine analogs 
5'-(N-ethyl)carboxamido-adenosine (NECA), 2-chloro-adenosine (2-Clado), N^-(R-
phenyl-isopropyl)-adenosine (R-PIA) and N^-(S-phenyl-isopropyl)-adenosine (S-PIA), 
increased granulosa cell ATP levels. FSH and luteinizing hormone (LH) decreased 
granulosa cell ATP levels in the presence and absence of adenosine. 
It has previously been shown that FSH and LH decrease oxygen consumption by 
cumulus-oocyte complexes and increase their lactate production. These effects have 
been suggested to be due to a competition of cofactors (e.g. ADP) common to 
glycolysis and respiratory chain. The fact that adenosine reversed the gonadotropin-
induced effects on oxygen consumption and lactate production support this theory. 
Adenosine and its analogs increased cAMP accumulation in luteal and granulosa 
cells only in the presence of gonadotropins and this effect was antagonized by the 
adenosine receptor antagonist 8-phenyl-theophylline (8-PHT). The EC50 for NECA 
on FSH stimulated cAMP accumulation was 40 jxM. Adenylate cyclase was stimu lated 
by adenosine analogs in membranes from non-luteinized, luteinized ovarian mem­
branes and in luteal cell homogenate (EC50 0.28-0.65 |xM for NECA). The effect of 
NECA was antagonized by 8-PHT. In the membranes the rank order of potency was 
NECA > 2-Clado > R-PIA > S-PIA, suggesting adenosine A2 receptors. 
In summary adenosine acts both as a substrate to intracellular metabolism and as 
an adenosine A2 receptor agonist in granulosa and luteal cell. A paracrine short 
loop positive feedback model was proposed where extracellular adenosine, derived 
from gonadotropin-induced extracellular increases in cAMP and decreases cellular 
ATP, enhanced exogenous hormone stimulation in granulosa and luteal cells. 
Key words: Adenosine, adenosine analogs, A2 adenosine receptor, adenylate cyclase, 
ATP, lactate, oxygen consumption, granulosa cells, cumulus-oocyte complex, luteal 
cells, rat 
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INTRODUCTION 
The endocrine regulation of ovarian function 
is classically co nsidered to be an integrated cyclic 
interplay between the ovary, in its various func­
tional stages, and the pituitary gland. The ovarian 
functional cyclicity is interrupted during pregnancy 
when placental hormones interact with the pituitary 
secretion of gonadotropins and ovarian steroid 
production. 
Gonadotropins 
The gonadotropins, follicle-stimulating hormone 
(FSH) and luteinizing hormone (LH), are secreted 
from the anterior lobe of the pituitary gland in 
a cyclic manner during fertile, non-pregnant 
periods. The gonadotropins meet the classical 
definition of a hormone: they are produced in 
certain cells, secreted into and transported by the 
blood to the target cells where they elicit their 
effects without being metabolized as a prere­
quisite for the hormonal effect to occur (Starling, 
1905a, b). 
On the external surface of ovarian cell mem­
branes specific receptors selectively bind LH or 
FSH. The hormonal stimulation is mediated in the 
cells by second messengers. The most well inves­
tigated second messenger for gonadotropins in 
ovarian cells is cyclic-3',5'-adenosine monophosphate 
(cAMP). Stimulation of the gonadotropin receptor 
activates membrane adenylate cyclase converting 
adenosine triphosphate (ATP) to cAMP. Cyclic 
AMP then binds to protein kinase A (PKA) which 
phosphorylates specific proteins. These proteins 
are believed to further mediate the different 
cellular responses of the gonadotropins. Under 
certain conditions also other second messenger 
systems mediate gonadotropin stimulation, e.g. 
the phosphoinositol turnover activates protein 
kinase C (PKC). 
LH and FSH have different physiological actions. 
FSH is considered to initiate the recruitment of 
follicles from a pool of small, preantral follicles 
which proliferate and differentiate first to antral 
and later to preovulatory follicles. FSH also 
stimulates follicular metabolism (e.g. steroid 
production) and differentiation (e.g. LH receptor 
development). However, LH also has a role for 
the differentiation of theca cells and thus for 
the supply of substrate for aromatization of 
androgens to estradiol in the granulosa cells. LH 
stimulates the preovulatory follicle to ovulate 
and induces maturational changes in the oocyte 
to make it fertilizable. Following ovulation, the 
remaining follicle differentiates into a corpus 
luteum. LH also stimulates luteal steroid production 
as well as other metabolic processes and supports 
luteal function. 
Even though the classical endocrine regulation 
of the ovary is precise and well tuned in its 
magnitude and cyclicity, gonadotropin action cannot 
alone be accounted for induction of all proliferative, 
differential and metabolic changes in the ovary. 
For instance, the first stages of follicular develop­
ment seem to be independent of FSH (Richards, 
1980). Furthermore, of the several millions of 
primordial follicles present at birth only a minute 
fraction will develop to preovulatory follicles. 
The majority of follicles will become atretic and 
never ovulate despite of the same gonadotropin 
environment as the subsequently ovulating follicles 
(Tsafriri and Braw, 1984). 
Local intercellular messenger molecules 
During the last decade attention has focused 
on the local regulators of ovarian function (Charm­
ing and Segal, 1982; Sharpe, 1984; Tsafriri, 1987). 
Within the gonads a multitude of different molecules 
locally produced can influence or regulate the 
neighboring cells or the producing cell itself 
(reviewed by Tsafriri, 1987). These factors do 
not make up one homogeneous group and a variety 
of effects elicited by these local factors have 
been registered. Among these factors/hormones 
in the ovary we find steroids, prostaglandins, 
growth factors (e.g. EGF, IGF-I, PDGF, TGFß), 
catecholamines and others that do not belong to 
the mentioned groups (e.g. GnRH) or that have 
not yet been chemically defined. 
These local intercellular messenger molecules 
have been proposed to be intraovarian hormones 
(cf Tsafriri, 1987), albeit they do not fulfill the 
criteria for a hormone of the classical endocrine 
type. The distance between production and release, 
on the one hand, and the target cell and hormone-
induced effects, on the other hand, is minute for 
"local hormones" as compared t o classical hormones 
such as FSH and LH. Furthermore, the "local 
hormones" are not necessarily transported via 
the blood to reach their target cell as the gonado­
tropins are. Moreover, the production of many of 
the "local hormones" are modulated by the clas­
sical hormones and their effects may be influenced 
by the "local hormones". The intraovarian hormones 
resemble the factors described as paracrine (Dock-
ray, 1979) and autocrine hormones (Sporn and 
Todaro, 1980). 
Adenosine as messenger molecule 
One substance that could be regarded as an 
intraovarian hormone is adenosine. In addition to 
being a precursor to many compounds crucial for 
life (ATP, RNA, DNA, NAD + , cAMP) adenosine is 
an agonist to extracellular receptors in many 
cells. Activation of adenosine rec eptors can regulate 
adenylate cyclase activity (Londos and Wolff, 
7 
1977; van Calker et al., 1979) and Ca^+ fluxes 
(Riberio and Sebastiao, 1986). 
In general, the adenosine action as receptor 
agonist, besides being substrate for intracellular 
metabolism, closely resembles the requirements 
for paracrine and autocrine action (Sporn and 
Tordaro, 1980). Adenosine is released locally, affects 
adjacent cells or the releasing cell itself a nd the 
release is locally regulated. Adenosine has also 
been proposed to be a local hormone (Arch and 
Newsholme, 1978) or local "retaliatory metabolite" 
(Newby, 1984). 
Several decades ago it was shown that infusion 
of adenosine or AMP reduced heart rate, blood 
pressure, inhibited intestinal movements and di­
lated coronary vessels in a number of animals 
(Drury and Szent-Györgyi, 1929). Since then 
adenosine has been shown to elicit a number of 
effects in adipose, neural, cardiac, hepatic, nephric, 
skeletal, endocrine and vascular tissue (Burnstock, 
1978; Daly, 1983 and references therein). In many 
instances a paracrine/autocrine relationship between 
the adenosine-releasing cell and the target cell 
has been postulated or established. 
In blood vessels, adenosine exhibits the well-
documented effect of vasodilation (Berne, 1964; 
Fredholm and Sollevi, 1986). Increase in adeno­
sine is believed to be caused by decreased oxy­
gen tension and, consequently, decreased ATP 
production. The ATP consumption results in 
increasing AMP levels and, instead of re-phospho-
rylation, this will result in an egress of AMP 
and adenosine from the tissue (Arch and News-
holme, 1978; Newby, 1984). The increase in extracel­
lular adenosine stimulates adenosine receptors 
and dilates the vessels, thereby restoring the blood 
flow and oxygenation of t he tissue (Newby, 1984; 
Bruns et al., 1987). Adenosine receptor-mediated 
effects on cAMP production have been demonstrated 
in endothelial and smooth muscle cells and also 
adenosine receptor-mediated inhibition of sym­
pathetic vasoconstrictor nerve activity (Fredhol m 
and Sollevi, 1986). Increased vascular adenosine 
levels induces dilation in co ronary, skeletal, brain 
and gastrointestinal vessels and increased blood 
flow and, hence, increased and restored oxygen 
tension. However, in the kidney adenosine has 
the opposite effect and induces vasoconstriction 
(Berne et al., 1983; Fredholm and Sollevi, 1986). 
These effects in blood vessels are mediated via 
adenosine receptors (Kusachi et al., 1983). 
Adenosine has been shown t o be released as a 
co-transmitter and to have both pre- and post­
synaptic adenosine receptor-mediated effects. In 
neural tissue adenosine receptor activation has 
been shown to both stimulate and inhibit cAMP 
accumulation as well as affect Ca^+ mobilization 
(Phillis and Barraco, 1985 and references therein). 
An anti-lipolytic effect by adenosine has been 
established in adipose tissue. Adenosine receptor 
activation mediates inhibition of lipolysis and 
cAMP formation in adipocytes (Fain, 1973; Schwabe 
et al., 1975; Fredholm, 1978b; Londos et al., 1978). 
Also in the gonads effects of adenosine have 
been observed. For instance, in the testis adenosine 
receptor binding has been demonstrated and 
adenosine receptor-mediated effects inhibit FSH-
induced cAMP formation and steroidogenesis 
(Murphy et al., 1983; Monaco et al., 1984; Eikvar 
et al., 1985). Adenosine causes a number of ef­
fects in the ovary such as increase of ATP levels 
and potentiation of gonadotropin-induced cAMP 
accumulation and steroidogenesis. These effects of 
adenosine in the ovary have been claimed to be 
due primarily to adenosine functioning as a sub­
strate for intracellular metabolism (Behrman et 
al., 1986). Even though the effects of adenosine 
in ovarian cells in vitro have been claimed to be 
due to metabolizable adenosine and not to adeno-
sine-receptor mediated effects, the possibility 
that adenosine acts as an adenosine receptor 
agonist in a paracrine/autocrine manner also in 
the ovary has not been thoroughly investigated. 
Adenosine and cell metabolism 
When studying the possible role of a denosine 
in a tissue, e.g. the ovary, knowledge of this 
molecule and its metabolism is necessary. A short 
review of some of the current data concerning 
the general fate and function of adenosine is 
therefore adequate. 
Adenosine is a nucleoside which consist of a 
nitrogenous purine base (adenine) and a sugar 
(D-ribose). The nucleotides AMP, ADP and ATP 
are phosphorylated and derived by estrification 
of the 5'-hydroxyl group in the pentose moiety of 
adenosine (fig 1). 
NH P  
G|  2  
OH OH 
Adenosine 
Fig 1 
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Adenosine has a fundamental role in cell 
metabolism. The fate of adenosine in the cell is 
complex but essential for cell function. Pro caryotic, 
eucaryotic and plant cells all utilize aden osine in 
energy transfer within the cell. Adenosine is 
also one of the precursors for nucleic acids and 
the synthesis of RNA and DNA. Moreover, coen­
zymes like FAD and NAD + are adenosine products. 
Cyclic AMP, a second messenger formed from 
ATP, is the intracellular link between several hor­
mones and their cellular effects. Adenosine also 
has a role in receptor-mediated intercellular 
communication, e.g. neural signal transmission, 
metabolically induced changes in tissue blood 
flow and as a modulator of cellular metabolism 
(fig 2). 
Cofactors 
DNA 
RNA Energy 
\  /  
Adenosine 
/ \ 
Receptor 
Second 
messenger 
Eia2-
Adenosine metabolism 
The formation of adenosine is accomplished 
through several pathways like de novo synthesis, 
dephosphorylation of A MP and degradation of S-
adenosylhomocysteine (fig 3). AMP is the most 
likely contributor of the bulk of " recirculating" 
adenosine within the cell. In general, the net 
addition of adenosine and purines in the cell is 
probably not derived from de novo synthesis in 
the cells but rather a result of uptake from the 
blood. The most likely local source for a denosine 
in the peripheral tissues is the erythrocyte. Red 
blood cells have the ability to take up purines in 
the liver, which is believed to produce purines 
and release them into the vessels (Murray et al., 
1970). It is also worth noting that adenosine 
does not seem to have a dietary origin (Salati et 
al., 1984). 
Adenosine deaminase (ADA) degrades adenosine 
to inosine (fig 3 and 4) and this enzyme has 
recently been cloned and sequenced (Wiginton 
et al., 1986). ADA is present in the cytosol of 
all tissues examined and ADA activity is also 
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Fig 3 
Formation and degradation of adenosine. 
For further details on localization and 
action see text. 
Nr Enzyme 
1 adenylate cyclase 
2 nucleoside diphosphokinase 
3 adenylate kinase 
4 phosphodiesterase 
5 adenosine kinase 
6 5'-nucleotidase 
7 adenosine deaminase 
8 purine nucleoside Phosphorylase 
9 xanthine oxidase 
10 S-adenosylhomocysteine 
hydrolase 
9 
Outside 
<0 
f \ /^Hypoxanthine 
/ Inosine 
cAMP AMP Adenosine/ 
1 
Adenine 
cAMP AMP Adenosine 
V Inosine 
\>/ ^"-»•Hypoxanthine 
Adenine 
CD 
"o a> 
3^ s c o 
a) 0 
3 ^  < o 
< 
o 
</> 
<D k. 
CT» 0} 
' CD O (/) 
-C O 
Q_ W-
O a> 
JZ <D 
CL TD 
a) o CD O 3 O C "O 
"lO "~ 
a) 
-g 
"cn O 
_a) 
o 3 O O 
CD CD 
•i i 
c "E OJ o T3 <T) 
< TD 
» w 
CD CD 
« -c 
a i-CD a cj 
Fiq 4 
Schematio presentation of adenosine metabolism and possible routes for transmembrane fluxes of adenosine 
and related compounds. For further details see text. 
present in the extracellular space. The Km for 
adenosine in this reaction ranges from 35 to 400 
(jlM (Fo x and Kelley, 1978) in different tissues. 
The 5'-hydroxyl group of adenosine seems to be 
a requirement for the enzyme activity (Nair and 
Weichert, 1980). 
Adenosine is phosphorylated by adenosine 
kinase to AMP. Adenosine kinase is also present 
in the cytosol of all tissues examined. The Km 
for adenosine in this reaction is 0.4-6(j,M (Fox 
and Kelley, 1978). Adenosine kinase accepts a 
wide range of adenosine analogs, but the enzyme 
seems to require an intact 5'-hydroxyl group of 
adenosine (Yamada et al., 1980). 
Other enzymes important for adenosine turn over 
are 5'-nucleotidase and phosphodiesterase (PDE). 
The enzyme 5'-nucleotidase catalyzes the de-
phosphorylation of AMP to adenosine. This enzyme 
is present both in the plasma membrane and in 
the cytosol and can dephosphorylate both intra-
and extracellular AMP (Bruns, 1980; Pearson et 
al, 1980). In different tissues the Km for this 
reaction is reported to be in the range from 10 
to 123 |xM (A rch and Newsholme, 1978; Fox and 
Kelley, 1978). Free ADP and ATP in micro-molar 
concentrations inhibit 5'-nucleotidase. However, 
almost all ADP and ATP in the cell is complex-
bound to Mg^ + and these complexes do not seem 
to inhibit the enzy me activity (Arch and Newsholme, 
1978). 
AMP is not only a product of A TP and ADP 
dephosphorylated in cellular energy transfer, but 
also of degradation of cAMP catalyzed by PDE. 
It is present both in the cytosol and at the external 
surface of the plasma membrane and consequently 
converts both extra- and intracellular cAMP to 
AMP (Rosberg et al., 1975; Arch and Newsholme, 
1978; Barber and Butcher, 1983). In the testis 
and the ovary the km is approximately 2 |iM 
(Conti et al., 1981, 1982, 1983, 1984). In the gonads 
there are also other PDE enzymes that catalyze 
the conversion of cGMP to GMP and one form 
that is calmodulin-calcium dependent (Purvis et 
al., 1981). Adenosine in milli-molar concentra­
tions has been shown to inhibit PDE to some 
extent (Gulyassy, 1971). Adenosine (0.2-2 mM) has 
been demonstrated to augment AC TH-stimulated 
steroidogenesis in normal rat adrenocortical tissue 
(Shönbaum et al., 1959) and in isolated rat adreno­
cortical cells (C ooper and Gleed, 1978). The latter 
authors concluded that the augmented steroido­
genesis was a result of adenosine inhibition of 
phosphodiesterase since theophylline, a PDE in­
hibitor, acted synergistically with adenosine. 
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Schematic presentation of glycolytic pathway, citric 
acid cycle and respiratory chain. 
ATP production 
Glycolysis and the respiratory chain are path­
ways where ADP is phosphorylated (fig 5). Glyco­
lysis converts glucose to pyruvate in the cytosol. 
If sufficient oxygen is present, pyruvate will be 
further degraded in a series of energy-yielding 
reactions in the citric acid cycle (Krebs cycle; 
Krebs and Johnson, 1937) in th e mitochondria. The 
citric acid cycle is the common pathway for the 
oxidation of glucose, fatty acids and proteins. 
The NADH and FADH2 transfer energy (i.e. elec­
trons) from the citric acid cycle to the respiratory 
chain. Electrons are transferred to O2 from NADH 
and FADH2 by a series of electron carriers to 
form ATP and H2O. This reaction is the process 
in which the largest amount of ADP is phosphory­
lated. Pyruvate is converted to lactate when the 
rate of production of pyruvate exceeds the rate 
of pyruvate oxidation in the citric acid cycle. In 
other words, when the NADH production in the 
glycolysis and citric acid cycle is greater than 
the oxidation rate in the respiratory chain lactate 
is formed in the cell. 
cAMP formation 
Upon hormonal stimulation, adenylate cyclase 
(fig 4) converts ATP to cyclic AMP (cAMP; Rail 
et al., 1957). cAMP is an intracellular second 
messenger to extracellular hormonal stimulation 
mediating a variety of physiological responses 
depending on the type of hormone. The activation 
of adenylate cyclase involves a specific hormone 
receptor (R) at the external surface of the cell 
membrane, the catalytic component (C) and the 
regulatory GTP-bindmg protein (G). The G com­
ponent is composed of several subunits and can 
be either stimulatory (Gs) or inhibitory (G;) on 
the C component. Thus, stimulation of adenylate 
cyclase involves R-Gs-C to increase cAMP produc­
tion, while inhibition of a denylate cyclase involves 
Gj instead of Gs (Gilman, 1987). A variety of 
hormones, among them gonadotropins, activate 
adenylate cyclase. 
Ectoenzymes 
Enzymes that are localized at the external 
surface of the plasma membrane and metabolize 
extracellular substrates are called ectoenzymes. 
Both 5'-nucleotidase and PDE are ectoenzymes 
(fig 4). Other ectoenzymes important in this context 
are nucleoside triphosphatase and nucleoside 
diphosphatase which catabolize extracellular ATP 
and ADP, respectively (Manery and Dryden, 1979; 
Pearson et al., 1980). Thus, adenosine can be 
derived from extracellular ATP, ADP, AMP and 
cAMP when these catalyzing enzymes are present 
and functional (Rosberg et al., 1975; Selstam and 
Rosberg, 1976; Arch ana Newsholme, 1978; Pearson 
et al., 1980; Bruns, 1980; Barber and Butcher, 1983). 
Uptake of adenosine into the cell 
Adenosine and other nucleosides can be transpor­
ted from the extracellular space across the cell 
membrane into the cell by facilitated diffusion. 
At physiological concentrations specific nucleoside 
carrier proteins transport nucleosides. The carrier 
proteins seem to be present in all mammalian 
cells (Arch and Newsholme, 1978; Fox and Kelley, 
1978; Young and Jarvis, 1985). Nucleosides can 
also be transported by s imple diffusion. Purine 
and pyrimidine bases share a common carrier 
protein distinct from the nucleoside carrier protein 
(Berlin and Oliver, 1975). 
As has been stressed by many authors, the 
rate of tra nslocation of nucleosides, like adenosine, 
from the exterior to the interior of the cells is 
dependent on two processes, the transport mecha­
nism itself and the intracellular metabolization 
(Berlin and Oliver, 1975). The intracellular con­
centrations of adenosine are very low, since the 
nucleoside is rapidly metabolized and a concentra­
tion gradient over the cell membrane is maintained. 
Thus, the translocation of a denosine is dependent 
on the kinetics of the carrier as well as the 
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kinetics of the intracellular adenosine kinase and 
ADA. This combined activity has been referred 
to as nucleoside uptake (Berlin and Oliver, 1975; 
Arch and Newsholme, 1978). In most studies on 
adenosine fluxes, nucleoside metabolism has not 
been inhibited resulting in kinetic data which 
represent both transport over the cell membrane 
and metabolism. 
Adenosine uptake is reversibly and competitively 
inhibited by other nucleosides since they use the 
same carrier. Other compounds, not using the 
nucleoside carrier for transport but inhibit uptake 
are dipyridamole (DIP), papaverine, hexobendine 
and reserpine (Arch and Newsholme, 1978). These 
latter inhibitors are not solely specific for nuc­
leoside uptake. For instance, in higher concen­
trations DIP may also inhibit phosphate fluxes. 
Also other substances not primarily used as 
transport inhibitors may interfere with the uptake, 
for example, the commonly used solvent dimethyl 
sulfoxide (DMSO) (Berlin and Oliver, 1975 and 
references therein). 
Release and removal of adenosine from the cell 
There are three principal ways in which adeno­
sine is removed from the cell: deamination, phos­
phorylation or release to the extracellular space 
as adenosine or adenosine derived compounds 
(AMP, ATP, cAMP). 
Since adenosine is transported by facilitated 
diffusion, adenosine efflux is dependent on higher 
intracellular than extracellular concentrations. 
Another suggested possibility for efflux o f adenos ine 
is the association of 5'-nucleotidase with the 
plasma membrane and its use of intracellular 
AMP as substrate for adenosine release into the 
extracellular space. Thus, 5'-nucleotidase functions 
both as a catalyzing enzyme and as a carrier for 
adenosine (Arch and Newsholme, 1978). Both 
mechanisms may exist and both require increased 
cellular AMP levels. Such increased levels of 
AMP may result from decreased re-phosphorylation 
due to hypoxia. In addition, AMP levels a re also 
increased by increased "cellular work" (e. g. meta­
bolic, biosynthetic, ion pumping, muscle contraction 
etc) causing higher ATP consumption or by other 
situations when the relative balance is shifted 
from phosphorylation to dephosphorylation. 
Extracellular adenosine may also be derived 
from cAMP. Cyclic AMP release is a common 
phenomenon during hormone stimulation of adenylate 
cyclase in many cells (Barber and Butcher, 1983).-
Fain and coworkers (1972) proposed that cAMP 
may be the precursor of extracellular adenosine 
in adipose tissue. The mechanism for deriving 
adenosine from cAMP involves the presence of 
extracellular PDE converting cAMP to AMP, and 
5'-nucleotidase which degrades AMP to adenosine. 
This hypothesis was abandoned later when they 
found no evidence for hormone-induced adenosine 
release in fat cells (Fain, 1979). However, theoreti ­
cally the proposal may still be valid for other 
tissues. 
Adenosine levels 
Under normal conditions the activity of the 
adenosine metabolism results in unmeasurable or 
very low concentrations of adenosine within the 
cell (Henderson, 1979). Outside the cell detectable 
amounts of adenosine can usually be found in 
the intercellular fluid, plasma or, under experimen­
tal conditions, in the medium. Under normal 
conditions the concentrations have been reported 
to be between 0.03-2.6 JJIM in mammalian body 
fluids and 1-30 nmol/g wet weight (approximately 
1-30 JIM) in tissue (reviewed in Arch and New-
sholme, 1978). However, both the treatment of 
the samples and the sampling procedure are criti­
cal since adenosine levels increase dramatically 
in hypoxic tissue. Adenosine is also subject to 
rapid degradation by endogenous enzymes present 
in the tissue such as ADA. As a consequence, a 
fairly high degree of v ariation in adenosine levels 
has been reported. 
Considerable species differences have also be en 
reported, the levels of adenosine in plasma ranging 
from less than 0.015 P-M in th e cat to 0.52 |XM in 
the rat. There are also strain differences in plasma 
adenosine levels within the same spec ies (Fredholm, 
1980b). Despite this, the estimation of physiologi­
cal concentrations of extracellular adenosine is 
of crucial importance for judgment of the validity 
of experimental data, in particular those evalu­
ating putative adenosine receptor actions. In this 
context, it is of interest to note that very little 
adenosine escapes via the general circulation 
from the organs and cells, where it is produced 
and released. The quantitatively most important 
removal of a denosine from the extracellular space 
is re -uptake by the cell from which it was released 
or by neighboring cells. 
Adenosine receptors 
As previously mentioned adenosine is not only 
a substrate but also exerts action without being 
metabolized. Adenosine conjugated to large mole­
cules that are thought not to enter cells mimics 
some of the actions of free adenosine (Olsson et 
al., 1976, 1977; Schräder et al., 1977; Fain and 
Shephard, 1979). These data, in combination with 
the variety of documented cellular effects of 
adenosine, were the basis for the concept of c ell 
surface receptors for adenosine. Different classes 
of purine and adenosine receptors have been 
identified based on agonist specificities and 
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functional responses. 
Purinoceptors 
Burnstock (1978) proposed the existence of two 
groups of membrane purinergic receptor sites 
based on the relative selective action of agonists 
(adenosine, ATP, A DP and AMP) and antagonists, 
in analogy with the classification of adrenergic 
receptors (a and ß receptors) and histamine 
receptors (HI and H2). The receptors were named 
PI and P2 purinoceptors (fig 6). He found the PI 
adenosine purinoceptor predominant in cardiovas­
cular beds, in the trachea and in the brain, while 
the P2 purine nucleotide purinoceptor was mainly 
found in the gastrointestinal tract and urogenital 
system. The PI purinoceptor was more sensitive 
to adenosine than to AMP and less sensitive to 
ADP and ATP (adenosine > AMP > ADP & ATP). The 
adenosine action on PI purinoceptors was competi­
tively antagonized by methylxanthines and the PI 
purinoceptor activation was coupled to adenylate 
cyclase activation. At the P2 purinoceptor the 
agonists have the reversed rank order of potency 
(ATP > ADP > AMP > adenosine) and was antagonized 
by quinidine instead of methylxanthine. Furthermore, 
activation of the P2 purinoceptor did not involve 
adenylate cyclase activation (Londos et al., 1983). 
Receptors with adenosine as agonist 
Londos and Wolff (1977) proposed that adenosine 
acts on receptors or adenosine-sensitive sites to 
inhibit or stimulate adenylate cyclase activity. 
Based on which part of the adenosine molecule 
that proved important for activation of the sites 
or receptors they were named R-site, the ribose 
moiety of adenosine being necessary for the 
activity, or P-site, the purine moiety being neces­
sary for the activity. 
Pi P2 
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Purine receptor nomenclature 
Even though adenosine activated both the It­
änd the P-sites (fig 6), these sites were distin­
guished by the use of analogs of adenosine modified 
in the purine or ribose moiety, respectively. Thus, 
2,,5'-dideoxyadenosine neither bound nor activated 
the R-site but was an agonist for the P-site 
(Haslam et al., 1978; Londos et al., 1983). The P-
site was found to be located on the internal 
surface of th e cell membrane (Haslam et al., 1978). 
It inhibited adenylate cyclase (Londos and Wolff, 
1977) and was not antagonized by methylxanthines. 
The affinity constant for the P-site was in the 
low to high micro-molar range for adenosine and 
analogs (table 1). The physiological significance, 
if any, of the P-site is unknown, since it is unlikely 
that intracellular concentrations ever reach micro-
molar concentrations in the living cell (Daly, 1983). 
The R-site was located on the external surface 
of the cell membrane, and was or iginally claimed 
only to stimulate adenylate cyclase (Londos and 
Wolff, 1977). However, van Calker and coworkers 
(1979) showed that activation of the R-site in 
cultured mouse brain cells not only stimulated 
but also inhibited adenylate cyclase depending on 
the concentration of a denosine. At concentrations 
of adenosine above the micromolar range, the 
cAMP levels in the cultures increased, while 
submicro-molar concentrations inhibited ß-adreno-
ceptor-stimulated cAMP accumulation. Based on 
these observations they suggested the name Aj 
receptor for those R-sites that mediated the 
inhibition and A2 receptors for those that mediated 
stimulation of ade nylate cyclase. They also showed 
that the Aj r<""*ptor-mediated inhibition was 
not equivalent to the inhibition mediated by the 
P-site, since the Aj receptor-mediated effect was 
dependent on the integrity of the ribose moiety 
and was antagonized by methylxanthine. Londos 
and coworkers (1980) confirmed that the R-site 
did have subclasses by studying adenosine analog 
stimulation of adenylate cyclase activation in 
hepatocytes and Leydig tumor cells and inhibition 
in adipocytes. They designated the subclasses R; 
and Ra for the adenosine receptors mediating 
inhibition and stimulation of adenylate cyclase, 
respectively. In the literature, Aj and R; are 
used as equivalent entities, and so are A2 and 
Ra. The terms and A2 will be used in the 
following discussion (fig 6). 
Methylxanthines antagonize adenosine action 
on the Aj and A2 receptors but not adenosine 
action on the P-site. Adenosine antagonists will 
be discussed below. 
The Aj and A2 receptors are not only distin­
guished by their opposite effects on adenylate 
cyclase, but also by the ranking of potencies of 
the different adenosine analogs. Some authors 
stress that the latter criterion for classification 
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Table 1 
property Type of receptor 
P-site 
Location 
Effect on AC 
Purine modified 
adenosine analogs 
Ribose modified* 
adenosine analogs 
GTP 
Relative potency 
NECA: EC,, range 
R-PIA: IC™ range 
Methylxanthine 
outer cell surface 
inhibition 
agonist 
poor effector 
required 
R-PIA>NECA 
100-500nM 
5-10nH 
antagonist 
outer cell surface cytoplasraatic cell surface 
stimulation inhibition 
agonist 
poor effector 
required 
NECA>R-PIA 
20nH-2nM 
ZOOnM-lOOuM 
antagonist 
poor effector 
agonist 
not required 
no effect 
•NECA, in contrast to most ribose-modified analogs, is a potent agonist at the A rec eptor. 
Table modified after Londos et al. (1983) 
is more correct since most, but not all, the effects 
of adenosine receptor are m ediated via adenylate 
cyclase (Fredholm, 1982b; Stone, 1983, 1984; 
Hamprecht and van Calker, 1985). For the most 
utilized adenosine analogs, the rank order of 
potency for the receptor is R-PIA >2-Clado>-
NECA>S-PIA and for the K~ i receptor NECA >2-
Clado > R-PIA > S-PIA (Daly, 1983). The half-maximal 
effect and affinity of the adenosine analogs to 
the receptors also differ between the Aj and A2 
receptor. The A^ receptor is considered to be a 
high affinity receptor with an IC50 in the nano­
molar range. The A2 receptor is described as a 
low affinity receptor with an EC50 in the low 
micromolar range (Daly, 1983; Londos et al., 1983). 
However, several groups have noted that the A2 
receptor affinity differs considerably between 
tissues (Daly et al., 1983, Londos et al., 1983; 
Elfman et al., 1984; Daly, 1985) and it seems 
likely that the A2 receptor can be further divided 
in two subclasses, one high (EC50 < 1 pM) and one 
low (EC50 > 5 p.M;Daly, 1985) affinity A2 receptor 
named A2a and A2b> r espectively (Bruns et al., 
1986,1987). 
The two functionally and pharmacologically 
distinct adenosine receptor-media ted effects coupled 
to adenylate cyclase are GTP-dependent like the 
effects of other hormones coupled to adenylate 
cyclase stimulation and inhibition (Londos et al., 
1979 ;Rodbell, 1980; Londos et al., 1983; Gilman, 
1987). However, not all adenosine receptor effects 
are mediated by adenylate cyclase. It has also 
been presented data demonstrating non-adenylate 
cyclase-mediated effects (e.g.; Wallace et al., 
1984; Dix et al., 1985; Fredholm et al., 1986; 
Challiss et al 1987; Fredholm and Lingren, 1987) . 
For instance, in cardiac muscle (Schräder et al., 
1975) and in neural tissue (Phillis and Wu, 1981) 
it has been shown that adenosine receptor activa­
tion is coupled to inhibition of Ca^+ fluxes. 
Adenosine receptor antagonists 
Sattin and Rail (1970) studying adenosine-induced 
cAMP accumulation in guinea pig brain cortex 
noted that methylxanthines blocked the effect of 
adenosine. Methylxanthines like caffeine, theophyl ­
line and IBMX are classical phosphodiesterase 
inhibitors (Amer and Kreighbaum, 1975), but they 
also are adenosine receptor antagonists blocking 
both A} and A2 receptors. The effect of methylxan­
thines on adenosine receptors are separated from 
their effect on phosphodiesterase. Methylxan­
thines binds to adenosine receptors at concentra­
tions lower than those required for inhibition of 
phosphodiesterase (Smellie et al., 1979). Further­
more, some alkylxanthines, such as 8-PHT (Griffith 
et al., 1981), are weak phosphodiesterase inh ibitors, 
but adequate and potent adenosine receptor 
antagonists. Unfortunately, methylxanthines do 
not discriminate between Aj and A2 receptors 
(Daly, 1982), but they are not antagonistic to 
the P-site or to the P2 receptor. 
The widespread effects of methylxanthines in 
the body have primarily been ascribed to their 
effects on the phosphodiesterase enzyme. Among 
these effects are CNS activat ion, enhanced lipoly sis, 
increased renal blood flow, increased release of 
catecholamines, increased heart r ate and force of 
contraction and inhibited anaphylactic broncho-
constriction. All these can be elicited by caf feine 
and theophylline, therapeutically or just from 
extensive coffee drinking. However, Fredholm 
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(1980a) suggested that these effects are due to 
adenosine receptor blockade, since opposite effects 
could be demonstrated with adenosine and its 
analogs in vivo or in vitro. This view also sheds 
some light on the physiological importance of 
adenosine and adenosine receptors. The reverse, 
that all effects of theophylline and caffeine are 
due to adenosine receptor antagonism, is probably 
not true since other effects of these substances 
may be operative clinically (Fredholm and Sollevi, 
1986). 
Adenosine receptor regulation 
The mechanism for the regulation of the 
adenosine receptors is not understood. However, 
a number of studies have been presented on changes 
in adenosine receptor responsiveness or agonist 
binding. One example of up-regulation of the 
adenosine receptor is prolonged treatment with 
adenosine receptor antagonist (caffeine and theo­
phylline) which increased the adenosine receptor 
binding to rat cerebral cortical membranes but 
did not change the adenosine receptor-mediated 
effect on cAMP accumulation (Fredholm, 1982a; 
Murray, 1982). 
Hormonal regulation of adenosine receptor 
number and responsiveness has been suggested. 
Adenosine receptor binding increased in the rat 
testis up to two month of ag e (Monaco and Conti, 
1986) and hypophysectomy decreased binding 
(Murphy et al., 1983). Moreover, smooth muscle 
contractility in the human oviduct was modulated 
by adenosine analogs and adenosine receptor 
responsiveness varied with the menstrual cycle 
(Wiklund et al., 1986). Differentiation of cells 
may also change the adenosine receptor expression. 
Preadipocytes expressed A2 receptors and when 
the cells differentiated to adipocytes the A2 
receptors decreased and concomitantly A^ receptors 
appeared (Ravid and Lowenstein, 1988). 
The molecular synthesis or composition of the 
adenosine receptor are at the present not known. 
Recently, a number of reports have been presented 
regarding the size of the A^ receptor. The reported 
size of t he A] receptor in testis using photoaffmity 
labelling technique was 42 kD (Stiles et al., 1986a), 
while the receptor size in fat cells and brain 
was slightly smaller, 38 kD (Stiles et al., 1986b). 
Another group has presented data for a receptor 
size of 34 kD protein (Linden et al., 1986) in 
cerebral cortex, while still others using other 
techniques suggested a larger molecular size. 
They also suggested it to be a dimer sized 79.5 
kD (Reddington et al., 1987) or 63 kD (Prez-Reyes 
et al., 1987). The lack of information on the size 
of the A2 receptor may be due to the low binding 
affinity to the A2 receptor as compared to the 
Ai receptor. 
AIM OF THE PRESENT INVESTIGATION 
Adenosine can be postulated to be involved in 
a number of cellular events in the ovary based 
on the above described effects of adenosine in 
cells in general. For instance, adenosine is an 
indispensible compound in energy metabolism 
and the carbohydrate metabolism in ovarian cells, 
these having a specialized high glycolytic capacity 
(Ahrén and Kostyo, 1963; Ahrén et al., 1969, 
1973, 1976). For example, as much as 80-90% of 
metabolized glucose is found as lactate in isolated 
follicles (Hillensjö, 1976), suggesting that the 
bulk of follicular ATP is derived from the glyco­
lysis. Furthermore, gonadotropins decrease both 
oxygen co nsumption in oocyte-cumulus complexes 
(Hillensjö et al, 1975) and the ATP content in 
prepubertal ovaries (Ahrén et al., 1968). Addition 
of adenosine increases the ATP, cAMP and steroido­
genesis levels in ovarian cells and the cellular 
effects of adenosine in the ovary have been 
proposed to be due mainly to adenosine metabolism 
(Behrman et al., 1986). 
The testis and the ovary, though differing in 
functional end products, share many metabolic 
characteristics, such as cAMP production and 
steroidogenic responses to gonadotropins (Baker 
et al., 1976; Richards 1980), as well a s the lactate 
production by supportive cells (i.e. Sertoli and 
granulosa cells; Mita et al., 1982; Le Gac et al., 
1983; Billig et al., 1983) and substrate requirements 
of the germ cells (i.e. spermatocytes and oocytes; 
Biggers et al., 1967; Kennedy and Donahue, 1969; 
Zeilmaker et al., 1974; Jutte et al., 1981; Robinson 
and Fritz, 1981). In the testis adenosine receptors 
have been demonstrated (Stiles et al.,1986a) and, 
when activated, these adenosine receptors exhibit 
functional responses (Monaco et al, 1984; Eikvar 
et al., 1985). The considerable similarities between 
the ovary and the testis suggest the presence of 
adenosine receptors also in the ovary. 
The aim of the present investigation was to 
study adenosine as substrate for cellular metabolism 
and as agonist to putative adenosine receptors in 
the ovary. 
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METHODS 
Animals 
Immature female Sprague-Dawley rats (Alab 
Ltd, Stockholm, Sweden) were kept under standar­
dized conditions with lights on between 0500-
1900 h and with 55-60% relative humidity. Water 
and pelleted food were given ad libitum. The 
animals arrived 2-6 days prior to the initiation 
of the experiments. 
Granulosa cell and cumulus complex isolation and 
incubation procedures 
The animals were given 10 IU pregnant mare's 
serum gonadotropin (PMSG, NIDDK), s.c., on day 
26 of life to induce follicular growth (Cole, 1936; 
Fuxe et al., 1972) and were killed by cervical 
dislocation 48-50 h later, before the endogenous 
LH/FSH surge (Hillensjö et al., 1974; Bauminger 
et al.,1978; Ekholm and Hillensjö, 1982). Ovaries 
were isolated aseptically and placed in incubation 
medium. Cumulus and mural granulosa cells were 
obtained by incising and gently squeezing the 
largest follicles in each ovary. Oocyte-cumulus 
complexes were separated from the granulosa 
cells with a micro-pipette under a dissection 
microscope (40x), washed twice, and approximately 
20 cumuli, with intact surrounding corona, from 
the same rat were incubated together. 
Granulosa cells from all rats in an experiment 
were pooled in one test tube, washed once in 
fresh medium and centrifuged for 5 min at 200xg. 
The cell concentration was estimated in a hema­
cytometer and viability (60-80%) was checked 
with the trypan blue exclusion test. The granulosa 
cells were cultured in 400 (j.1 medium in multiwell 
culture plates (Costar, Cambridge, MA) at 37C in 
humidified air or 5% CO2 in humidified air for 
varying periods of time. 
At the end of the incubation period aliquots of 
medium were frozen for later determinations of 
lactate, progesterone and cAMP. To determine 
ATP the incubations were terminated by the 
addition of 100 |xl 50% trichloroacetic acid and 
sonicated. These terminated incubations were 
stored at 4C until the ATP assay was carried 
out later the same day. 
Luteal cell preparation and incu bation procedure 
To obtain heavily luteinized ovaries, rats were 
injected s.c. with 50 IU of PMSG (NIADDK) at 
day 26 of life, followed by 25 IU of hC G (Gonadex) 
56 h later (Parlow, 1961). The animals were killed 
by cervical dislocation 2, 5 or 6 days after the 
hCG injection. The luteal cells were prepared 
from the heavily luteinized ovaries with an en­
zymatic digestion method according to Sender 
Baum and Rosberg (1987). Cell number was estimated 
with a hemocytometer and viability (95%) was 
checked with the trypan blue exclusion test. The 
luteal cells (2x10^ cells/well) were incubated in 
500 |xl medium in multiwell culture plates (Costar, 
Cambridge, MA). The incubations were kept at 
37C in humidified air for 180 min, unless otherwise 
indicated. 
Incubation medium 
Eagle's Minimum Essential Medium (Gibco, 
Paisley, Scotland) with Earle's salts was used, 
HEPES (10 mM) and BSA (0.1%). When incubated 
in 5% CO2 it was also supplemented with NaHCÛ3 
(2.19 g/1). The medium was stored frozen until 
the day of experiment. 
Hormones and chemicals 
Stock solution of ovine FSH (0.1 mg/ml; 
NIAMDD-oFSH-15, 20 U/mg; contamination LH 
0.04 U of NIH-LH-Sl/mg and TSH, GH, PRL < 
0.1% by weight), human FSH (gift from Dr P 
Torjesen, Oslo, Norway), ovine LH (0.1 mg/ml; 
NIAMDD-oLH-24, 2.3 U/mg; contamination GH, 
PRL < 0.1% by weight and TSH, FSH < 0.5% by 
weight) and hCG (1000 IU/ml; Gonadex, Leo, 
Helsingborg, Sweden; 0.1 mg/ml) in sterile PBS 
with 0.1% BSA and PMSG (400 IU/ml; NIADDK) 
in 0.9% NaCl were kept frozen at -20C until use. 
NECA (5'-(N-ethyl)-carboxamido-adenosine), R-
PIA (N°-(R-phenyl-isopropyl)-adenosine) and S-
PIA (N^-(S-phenyl-isopropyl)-adenosine) (Boeh-
ringer-Mannheim, Mannheim, FRG) and 2-Clado 
(2-chloro-adenosine; Sigma, St Louis, MO) were 
dissolved in the medium by mixing and short 
sonication. Stock solutions of a denosine deaminase 
(ADA, Boehringer-Mannheim; 400 U/ml in glycerol), 
8-phenyltheophylline (8-PHT, Sigma; 20 mM in 
0.1 M NaOH), 8-(p-sulfo)-phenyltheophylline (PSOT, 
a g ift from Dr L Gustafsson, Karolinska Institute, 
Stockholm, Sweden), Ro 20-1724 (a gift from 
Hoffman LaRoche, Basel, Switzerland; 500 mM in 
95% ethanol) and dipyridamole (DIP, Sigma; 20 
mM in 95% ethanol) were diluted in medium, [a-
32P]ATP, [3H]CAMP and [l,2,6,7-3H]progesterone 
were all purchased from Amersham International 
(Buckinghamshire, UK). 
cAMP assay 
cAMP was determined in aliquots taken from 
the medium immediately after the incubation, 
since the major part of cAMP was found in the 
medium after stimulation of the cells with FSH 
both in the absence and in the presence of adeno­
sine analogs and other compounds used. The 
intracellular cAMP comprised 25 ± 2 % of total 
cAMP in all gro ups incubated with FSH in different 
combinations with adenosine and its analogs, DIP 
and 8-PHT for 3h. Intracellular cAMP was below 
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detection limit in groups without FSH. The aliquots 
of medium were kept frozen at -20C until analysis 
within one week after the experiment. cAMP was 
determined according to Gilman (1970) with cAMP-
dependent protein kinase as binding protein. Dextran 
coated charcoal (charcoal 5 g/ml and Dextran 50 
p-g/ml) was u sed to separate free and bound cAMP. 
The sensitivity of the cAMP assay was approximate ­
ly 0.5 pmol/tube and the coefficient of intra-
assay variation was 15%. 
Progesterone assay 
Progesterone was determined by radioimmuno­
assay (RIA) and was determined in unextracted 
aliquots of incubation medium. The progesterone 
antibody was purchased from ICM Immuno-Chemicals 
(Tumba, Sweden). High correlation has been found 
between values obtained with direct RIA compared 
to values obtained in lipid-extracted medium samples 
(r = 0.98; Hedin, 1984). The intra-assay and inter-
assay variations were 11% and 15%, respectively. 
Cross reaction with other substances used in the 
experiments and other steroids (estrogen and 
testosterone) was less than 1%. The standard 
curve (6.25-800 pmol/tube) was calculated using a 
logit-log transformation of standards. 
Lactate assay 
Lactate was measured with a fluorimetric method 
according to Passonneau (1974) with some modifica­
tions. Perchloric acid (HCIO4, 3 M) was used to 
precipitate the proteins. After centrifugation, the 
supernatant was neutralized with potassium hydrogen 
carbonate (KHCO3, 3 M). After a second centrifuga­
tion, carbonate buffer (0.1 M. pH 9.7; Lowry et 
al., 1964) was added to the samples taken from 
the supernatant. Lactate dehydrogenase (LDH, 
from beef heart, 10 jxg) an d nicotinamide-adenine 
dinucleotide (ß-NAD, 1.5 ixmol) were finally added 
to the samples. The reaction was carried out at 
room temperature (20C) for 30 min. The NADH 
produced was recorded using a spectrophotofluoro-
meter (Aminco-Bowman) at excitation and emission 
wavelengths of 340 nm and 450 nm, respectively. 
A standard curve (10~9,10"1 M) for lactate was 
constructed using serial dilutions of a 1 M lactate 
solution treated in a manner the same manner as 
the samples. 
ATP assay 
The ATP assay was based on the luciferin-
luciferase enzyme luminescence method (Strehler 
and Totter, 1952; Lyman and DeVincenzo, 1967). 
The sonicated and trichloroacetic acid-treated 
cell suspension (0.5 ml) was extracted three times 
with 4 ml diethylether. ATP standards (1.5-800 
pmol) and blanks were treated identically. The 
assay was linear at least down to 1.5 pmol ATP. 
The emitted light from the luciferin-luciferase 
reaction was recorded using a spectrophotofluoro-
meter with a photon counter (Aminco-Bowman, 
American Instrument Co., Silver Spring, MD) at 
555 nm, with the primary light source disconnected. 
The buffered luciferin-luciferase (16 mg/ml; ATP 
bioluminescences, CLS, Boehringer-Mannheim, 
Mannheim, West-Germany) was dissolved in 10% 
glycerol-1% BS A in distilled water and kept in a 
light-shielded bottle. Aliquots (100 JJUI) of the 
ether-extracted samples were added to plastic 
tubes, and the reaction was started by adding 
100 |xl of the luciferin-luciferase solution (final 
pH 7.0). The emitted light was stable for several 
minutes. The coefficient of intra-assay variation 
was 4.7%. 
Adenylate cyclase assay and membrane preparation 
Membranes were prepared from preovulatory 
ovaries isolated 2 days after the PMSG injection 
(ovarian membranes) and from heavily luteinized 
ovaries were isolated 5 days after the hCG injection 
(luteal membranes). The ovaries were trimmed 
from adnexal tissues and kept frozen at -70C 
until assayed within 2 weeks. At the time of the 
assay, the frozen ovaries were homogenized in 
ice-cold Tris-sucrose buffer (25 mM Tris-HCl, 
5 mM MgCl2, 1 mM EDTA, 27% sucrose, pH 7.5) 
with an all glass Dounce homogenizer. The homo-
genate was centrifuged for 5 min at 160xg to 
remove debris, filtered through two layers cheese 
cloth and centrifuged again for 50 min at 10 
OOOxg. The crude membrane fraction was resuspen-
ded in Tris-sucrose buffer and aliquots of this 
suspension were used in the adenylate cyclase 
assay. 
In the experiments where adenylate cyclase 
activity in isolated luteal cells was studied, the 
cells were isolated as described earlier (Sender 
Baum and Rosberg, 1987), frozen in Tris-sucrose 
buffer and kept frozen until assayed within 2 
weeks. The cells were homogenized as described 
above, but the homogenate was not centrifuged 
prior to the adenylate cyclase assay. 
The final concentrations of reagents in the 
adenylate cyclase assay were: 0.1 mM ATP (with 
approximately 2x10^ cpm [a-32p]ATP), 0.1 mM 
cAMP, 0.05 mM GTP, 5 mM creatine phosphate, 
25 U/ml creatine Phosphokinase, 5 mM MgCl2 and 
1 U/ml ADA in 25 mM Tris-HCl at pH 7.5. The 
reaction was initiated by the addition of 100 jxl 
membrane suspension to 100 jil assay medium. 
After 10 min at 37C, the reaction was terminated 
by the addition of 100 |il stopping solution (5 mM 
cAMP, 20 mM ATP and 1% Na-dodecylsulfate). 
The [32p]cAMP formed was isolated by Dowex 
and alumina column chromatography (Salomon et 
al., 1974), with added [^H]cAMP for recovery 
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correction. The eluates from the alumina columns 
were collected directly into scintillation vials, 
mixed with scintillation fluid and counted for 
radioactivity. Protein contents of the membrane 
aliquots (80-120 |j.g/sample) were determined with 
the Lowry method (1951), after precipitation with 
ice-cold 10% trichloroacetic acid. The described 
adenylate cyclase assay is essentially the assay 
presented by Birnbaumer and coworkers (1976) 
with the omission of myokinase. 
The relatively poor adenylate cyclase activation 
(approximately 30% above basal activity for the 
adenosine analogs, 60% for FSH and hardly any 
for LH) might be explained by the low ATP 
concentration (0.1 mM) in the assay system. The 
rationale for choosing such a low concentration 
was to minimize adenosine contamination. How­
ever, Birnbaumer and coworkers (1976) have pointed 
out that membranes contain sufficient nucleoside 
triphosphate pyrophosphohydrolase activity to 
convert ATP to AMP without forming ADP, at 
least luteal membranes. Such mechanism would 
impair the ATP-regenerating system composed of 
creatinine phosphate and creatinine Phosphokinase 
from efficiently converting ADP to ATP iii the 
assay cocktail and would thus decrease the sub­
strate availability to the adenylate cyclase. The 
strategy to circumvent this problem would be to 
either increase the ATP concentration or add 
adenylate kinase (myokinase) that converts AMP 
to ADP (Birnbaumer et al., 1976). However, basal 
cAMP production was linear over 20 min with 
and without 0.1 U/ml myokinase and forskolin-
stimulated (50 |iM) luteal membrane adenylate 
cyclase to the same extent in the absence and 
presence of myokinase. These results suggested 
sufficient ATP in the assay for the amount mem­
branes used. 
Adenosine transport 
In paper I, adenosine uptake was estimated by 
incubating granulosa cells in culture medium with 
[^Hjadenosine (0.5-100 jxM; 5-10 |xCi/tube) at 37C. 
At specified time intervals, the cells were separated 
from the medium by filtration on Millipore filters 
(0.45 ^m; HAWP 02500, Millipore Corp, Bedford, 
MA). The filters were then washed six times 
with 2 ml ice-cold buffer (150 mM NaCl, 10 mM 
HEPES, 5 ml CaCl2, and 0.1% BSA, pH 7.4), 
transferred with cells to scintillation vials, dried 
over night and dissolved in 2 ml ethyleneglycol-
mono-methylether. Ten milliliters of scintillation 
fluid [2,5-diphenyloxazole (2.5 g/1) and l,4-bis[2-
(5-phenyloxazolyl)] benzene (0.2 g/1) in toluene] 
were added, and the radioactivity was determined 
in a liquid scintillation counter. 
In paper III, the adenosine uptake weis estimated 
by a modified method. Granulosa cells (10^ cells 
per sample), [^HJadenosine (100 p,M, 5-10 |j,Ci/sam-
ple) and indicated test substances in a total volume 
of 100 |j.l were layered on top of 300 |j,l 7.5% 
Percoll solution (Pharmacia, Uppsala, Sweden) in 
400 (j.1 Beckman microfuge tubes. The tubes were 
incubated at room temperature for the time 
indicated (21-23C) and were then centrifuged for 
1 min at 8500xg in a Beckman microfuge to 
sediment the cells through the Percoll layer. The 
centrifuged tubes were rapidly frozen at -80C. 
The frozen tips of the tubes, with the sedimented 
cell layer, were cut off, placed in scintillation 
vials together with scintillation fluid and counted 
for radioactivity. Less than 0.05% of the labelled 
medium, approximately 2% of the radioactivity in 
control cells, was found in the tip of the tubes. 
When calculating the Km and Vmax for the 
uptake kinetics of adenosine by the cells obtained 
values were fitted to a Michaelis-Menten curve 
with nonlinear regression. The calculated Km gave 
an approximation of the true Km value for adeno­
sine uptake since no equilibrium of adenosine 
was established due to nucleoside metabolism. 
The calculated values are given as mean ± SD. 
Oxygen consumption 
Oxygen consumption was determined with a 
microspectrophotometric method originally developed 
by Hultborn (1974). Single cumulus-oocyte complexes 
were placed in a small (12.3 nl), gas-tight, cylindri­
cal cuvette containing culture medium with 20-40 
p.M ox yhemoglobin. The increase in absorbance at 
435 nm, reflecting dissociation of oxyhemoglobin 
due to the gradual decrease in oxygen tension, 
was recorded in a thermostat-controlled (37C) 
Zeiss single-beam microphotometer. The duration 
of each measurement was 5-15 min, and the 
respiration was expressed as nl oxygen/h/cumulus-
oocyte complex (Magnusson et al., 1977; Magnusson, 
1980). 
Statistics 
Each experiment was repeated three or more 
times. Resulting values are given as mean ± SEM 
of triplicate samples, if not otherwise stated. 
When appropriate, logarithmically transformed 
data were used to obtain homogeneous variances. 
Differences between groups were calculated by 
analysis of variance, followed by Student-Newman-
Keuls' multiple range test (Woolf, 1968). For some 
comparisons, the Wilcoxon signed ranks test for 
two samples was used (Colquhon, 1971). A p-value 
less than 0.05 was considered significant. The 
dose-response curves were fitted with nonlinear 
regression to 4-parametric dose-response curves 
(Mcintosh and Mcintosh, 1980). The calculated 
ÈC50 and slope values from these curves are 
given as mean ± SD. 
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Table 2 
Effect of forskolin on ATP levels in granulosa cells. 
ATP 
(pmol/10 c ells) 
il 
Control forskolin 
0 80 ± 4 51 ± 3 
0.1 81 ± 4 48 ± 2 
1 87 ± 2 54 ± 1 
10 239 ±17 128 ± 7 
100 248 ± 7 217 ±15 
Granulosa cells (2*10 cells/well) were incubated in humidified air (37C) 
for 90 min with adenosine (ADO) in the ab sence or presence of forskolin 
(100 jiM). Each value re presents the me an ± SEM for triplicate samples. 
RESULTS AND COMMENTS 
In this section the results in paper I-V will 
be summarized and, in part, commented on. Some 
additional data is also included. 
One specific problem studying adenosine, or 
for that matter other substances with postulated 
autocrine/paracrine or local actions, is th e unin­
tended interaction between the administered 
experimental substance and the putative endogenous 
substance, both produced and present. In the 
case of adenosine, there is also the difficulty of 
separately studying intra- and extracellular actions 
of adenosine. In an effort to bypass some of 
these problems different cell preparations have 
been studied. Moreover, adenosine analogs, adeno­
sine transport inhibitor, adenosine receptor an­
tagonists and adenosine deaminase have been 
used in an attempt to more selectively study 
intra- and extracellular effects of adenosine. 
Besides adenylate cyclase activation and cAMP 
accumulation, oxygen consumption, lactate and 
progesterone accumulation and changes in cellular 
ATP levels have been used as functional parame ters 
for adenosine action in ovarian cells and membra­
nes. 
Adenosine uptake in ovarian cells (papers I and III) 
Adenosine is taken up by granulosa cells, but 
compared to luteal cells and most other cells 
from non-gonadal tissue, the uptake of adenosine 
by granulosa cells was slower (Berlin and Oliver, 
1975; Arch and Newsholme, 1978). The Km was 
found to be 15.9 ± 4 jxM in granulosa cells as 
compared to 19.4 ± 8 |xM in luteal cells. However, 
the Vmax was considerably lower in granulosa 
cells (1.6 ± 0.1 pmol/min/10^ cells) than in luteal 
cells (4.1 ± 0.6 pmol/min/10^ cells). The uptake 
of adenosine in granulosa cells was slower in the 
presence of FSH than in the absence (paper I). 
The nucleoside transport inhibitor DIP almost 
completely (90%) inhibited adenosine uptake. 
Furthermore, both R-PIA and S-PIA inhibited 
adenosine uptake almost as well as DIP did. Ino-
sine and NECA in concentrations equimolar to 
adenosine decreased the uptake of adenosine by 
25-40% suggesting that N ECA and inosine compete 
for the same carrier as adenosine. The receptor 
antagonist 8-PHT did not appreciably affect adeno­
sine uptake (paper III). 
- Adenosine is t aken up by granulosa and luteal 
cells 
Effects of gonadotropins, adenosine and adenosine-
derived compounds on ATP levels in granulosa 
cells and cumulus-oocyte complexes (papers I, II 
and III) 
In the presence of adenosine, the ATP content 
in incubated granulosa cells increased for at least 
225 min (paper I). In this respect the granulosa 
cells were slower than lu teal cells where a maximum 
was reached already within 15 min (Behrman et 
al., 1983b). FSH decreased the adenosine-aug-
mented ATP levels in granulosa cells, an effect 
which diminished with time. In addition, without 
adenosine added, FSH suppressed the levels of 
ATP (paper I). As in granulosa cells, the adenosine-
induced increase in ATP levels in cumulus-oocyte 
complexes were diminished by FSH (paper II). 
Adenosine was phosphorylated, according to 
measurements of cellular ATP levels, in a dose-
dependent manner in both granulosa cells and 
cumulus-oocyte complexes. Adenylate cy clase activa­
tion seems to be the common denominator for 
the decrease in ATP levels in granulosa cells 
since LH (paper I), FSH (papers I and II) and 
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forskolin (table 2) all induced a decrease in cel­
lular ATP levels. 
Thus, FSH depressed both the cellular content 
of A TP and the uptake of ade nosine in granulosa 
cells. However, the suppressive effect of FSH on 
cellular ATP levels was probably not a result 
only of de creased adenosine transport but also of 
FSH-induced intracellular processes such as adeno­
sine metabolism. This can be appreciated from 
paper I in which FSH depressed ATP levels in 
adenosine-preincubated cells where adenosine 
transportion and phosphorylation were permitted 
for 90 min before FSH was added (paper I). The 
adenosine analogs NECA, 2-Clado, R-PIA and S-
PIA did not significantly increase ATP levels in 
the granulosa cells. The decreasing effect of FSH 
(paper I) was still present with all analogs since 
they did not increase the ATP levels (paper III). 
The analogs, in this respect, were considered non-
metabolizable. 
Inosine dose-dependently increased ATP levels, 
but the increase was blocked by DIP (paper I). 
Cyclic AMP added to the incubation medium also 
increased ATP levels in granulosa cells. The effect 
was not as fast as the adenosine-induced ATP 
increases. The ATP increase was dependent on 
both PDE activity and nucleoside transport since 
a PDE inhibitor (Ro 20-1724) and DIP both inhibited 
cAMP-induced ATP increases in the cells (tables 
3 and 4). These results suggest that extracellular 
cAMP is converted to AMP by PDE and further 
metabolized to adenosine which then is transported 
into the cell where it is phosphorylated to ATP. 
k r cAMP 
A'• adenosine 
[]: gonadotropin 
S . gonadotropin 'receptor 
Adenosine is metabolized and increases cel­
lular ATP levels in granulosa cells and cumulus-
oocyte complex 
FSH, LH and forskolin decreases granulosa 
cell ATP levels 
- Adenosine analogs do not increase cellular 
ATP levels 
- Extracellular cAMP is metabolized to adenosine 
and increases ATP in granulosa cells 
Effect of adenosine on oxygen consumption and 
lactate formation in follicular cells (paper II) 
Whole follicles (Nilsson 1974; Tsafriri et al., 
1976a), cumulus-oocyte complexes and granulosa 
cells (Billig et al., 1983; Billig et al., 1984) have 
a high glycolytic capacity measured as lactate 
accumulation and the lactate production is stimu­
lated by gonadotropins, in spite of hyper-phy siologi­
cal oxygen tension during the incubation. Further­
more, gonadotropins also decrease oxygen con­
sumption in cumulus-oocyte complexes (Dekel et 
al., 1976; Magnusson and Hillensjö, 1981). It has 
been suggested, in earlier works from our labora­
tory, that this gonadotropin-induced decrease in 
oxygen co nsumption and concomitantly increased 
lactate accumulation could be due to competition 
for a limited supply of cofactors common to both 
glycolysis and oxidative phosphorylation. 
If adenosine-derived cofactors (AMP, ADP) 
were limiting factors then addition of adenosine 
would reverse the above mentioned gonadotropin-
induced effects. Addition of low concentrations 
of a denosine reversed the FSH-induced decrease 
in oxygen consumption while other nucleosides or 
an adenosine analog did not. When the adenosine 
uptake into the cells was blocked by DIP, the 
reversal of oxygen consumption was abolished. 
Furthermore, if the limitation of ADP was the 
cause of diminished respiration and if th e added 
adenosine after phosphorylation increased the 
ADP pool, then adenosine kinase had to be active. 
Enzyme activity is temperature-dependent and, 
when the cumulus complexes were incubated with 
adenosine at room temperature, the reversal of 
FSH-inhibited respiratory rate was not seen (paper 
n). 
If adenosine increased a former limited pool 
of cofactors common, ADP according to the 
suggestion, for the glycolytic pathway and the 
respiratory chain, then pyruvate would en ter the 
citric acid cycle at a higher rate and less lactate 
would accumulate. Indeed, when adenosine was 
added to the incubated cumulus-oocyte complex, 
lactate accumulation decreased both in the absence 
and presence of FSH (paper II). In FSH and LH-
stimulated granulosa cells adenosine decreased 
lactate formation as in cumulus-oocytes complexes 
(table 5). 
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Table 3 
Effect of cAMP and adenosine on ATP levels In granulosa cells In the pre­
sence and absence of DIP. 
ATP 
(pmol/105 cells) 
Incubation Control cAMP ADO 
time 
(min) -DIP +DIP -DIP +DIP -DIP +D1P 
15 54 ± 2 59 ± 2 60 ± 2 71 ± 2 100 ± 3 58 ± 1 
90 77 ± 4 71 t 3 93 ± 6 84 ± 1 305 ±16 108 ±12 
180 91 ± 3 88 ± 8 127 ± 3 96 ± 5 387 ±20 126 ±15 
360 131 ± 4 107 ± 6 280 ±16 137 ± 1 434 ±18 195 ± 7 
Granulosa cells (2*10 cells/well) were Incubated In humidified air (37C) 
for the indicated time in the ab sence or pr esence of cAMP (50 iiM) and 
adenosine (ADO, 50 nM) with and without DI P (10 iiH). Ea ch value re­
presents the me an ± SEM for triplicate samples. 
Table 4 
Effect of cAMP in the presence and absence of Ro 20-1724 and DIP, respec­
tively, on ATP levels in granulosa cells. 
ATP 
(pmol/105 cells) 
Control DIP Ro 20-1724 
Control 39 ± 2 36 ± 2 35 ± 2 
cAMP 95 ± 5 36 ± 5 39 ± 3 
FSH 27 ± 2 25 ± 2 19 ± 1 
FSH + cAMP 66 ± 2 30 ± 1 24 ± 1 
Granulosa cells (2*10 cells/well) were incubated in humidified air (37C) 
for 360 min in the absence or presence of cAMP (50 iiM), FSH (100 ng/ml), 
OIP (10 nM) and Ro 20-1724 (1 mM). Each value re presents the mean ± SEM 
of triplicate samples. 
Table 5 
Effect of ad enosine (ADO) on lactate accumulation in granulosa cells in 
the presence and absence FSH and LH, respectively. 
Lactate 
(nmol/105 cells) 
Incubation Control FSH LH 
time 
(h) -ADO +AD0 -ADO +AD0 -ADO +AD0 
4 12 ± 3 4 ± 1 28 ± 2 20 ± 2 29 ± 1 16 ± 3 
24 35 ± 2 12 ± 3 121 ± 7 30 ± 2 103 ± 5 24 ± 2 
Granulosa cells (2*105 cells/well) were incubated in humidified air (37C) 
for the indicated time in the absence or presence of FSH (100 ng/ml) or 
LH (100 ng/ml) with and without ad enosine (ADO; 50 nM). Each value re­
presents the mean ± SEM, n»6. 
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- Adenosine reverses FSH-induced decrease in 
oxygen consumption in cumulus-oocyte complexes 
- Adenosine decreases lactate formation in 
granulosa cells and cumulus-oocytes complexes 
Effect of adenosine on cAMP accumulation in 
ovarian cells (papers I, III and V) 
Adenosine (50 |iM) slightly increased the basal 
cAMP levels in the medium during a 90 min 
incubation of granulosa cells. FSH-stimulated 
cAMP accumulation was dose-dependently poten­
tiated by adenosine. The maximal adenosine poten­
tiation of maximally FSH-stimulated cAMP accumula­
tion was 5-10 fold. LH-stimulated cAMP accumula­
tion was also potentiated, but not to the same 
extent as with FSH (paper I). These results could 
be due to two principally different mechanisms 
(or a combination of both): adenosine could increase 
ATP levels and, thus, increase the substrate availa­
bility to the adenylate cyclase or adenosine could 
act as an agonist to the stimulatory adenosine 
receptor (A2). To investigate the latter possibili­
ty, metabolization of adenosin e had to be prevented 
and for this purpose adenosine analogs (NECA, 
2-Clado, R-PIA and S-PIA) were used. 
Adenosine A2 receptors coupled to adenylate 
cyclase present in ovarian cells should fulfill the 
following four criteria (see Introduction): 1) 
Adenosine and adenosine analogs should both 
stimulate adenylate cyclase activity and cAMP 
production. 2) The EC50 of NECA should be in 
the low micromolar or high nanomolar range. 3) 
The effect of NECA should be antagonized by a 
xanthine like theophylline, IBMX, 8-PHT 4) The 
rank order of potency of adenosi ne analogs should 
be NECA > 2-Clado > R-PIA > S-PIA according 
to the convention. 
In initial experiments with adenosine analogs 
2-Clado, in combination with max imally stimulatory 
concentrations of FSH, inconsistently enhanced 
cAMP accumulation (paper I). Extended studies 
showed that the non-metabolizable adenosine 
analog dose-dependently increased the cAMP 
accumulation in granulosa cells in spite of no 
increase in ATP levels. In combination with FSH, 
adenosine, NECA and 2-Clado elicited a marked 
dose-dependent potentiation of the cAMP accumula­
tion (paper III). The EC50 value for NECA on 
FSH-stimulated cAMP accumulation was found to 
be 40 (j.M. NE CA (100 (xM) ad ditively increased 
the cAMP accumulation for the whole dose range 
of FSH stimulation. Even at maximal stimulation 
of FSH, NECA increased the cAMP accumulation. 
In addition, LH-stimulated cAMP was increased 
(paper III). 
Since NECA was considered t o be non-metabo­
lizable and still increased cAMP accumulation, 
the results suggested that the effect was not due 
to increased substrate availability to adenylate 
cyclase, but rather due to inhibited PDE or to 
actual increases of adenylate cyclase activity 
mediated via A 2 receptors. If this was the case, 
in spite of the high EC50 compared to EC50 in 
other tissues (see Introduction), then the ade­
nosine receptor antagonists should counteract the 
effect of N ECA. However, the adenosine receptor 
antagonist 8-PHT dose-dependently decreased 
FSH-stimulated cAMP accumulation. This finding 
might be explained either by an unspecific effect 
of 8-PHT or by adenosine receptor antagonistic 
effect of 8-PHT inhibiting the effects of endogen-
ously produced and released adenosine. 
Adenosine deaminase, ADA, was added to 
the incubations to circumvent the effect of any 
assumed endogenous adenosine release. ADA 
degrades adenosine to inosine, which is not an 
adenosine receptor agonist. However, 8-PHT still 
decreased FSH-stimulated cAMP accumulation. 
Moreover, the attenuating effect on FSH action 
was even further enhanced. This finding may be 
explained by an unspecific effect of 8-PHT. 
Alternatively ADA was ineffective in degrading 
endogenous adenosine or inosine had an effect 
on FSH-stimulated cAMP accumulation. Indeed, 
inosine increased ATP levels and potentiated 
FSH-stimulated cAMP accumulation. The effects 
were blocked by D IP. The results indicate that 
the latter possibility seems the most likely, but 
does not exclude the former. 
Nucleosides, including inosine, use the same 
carrier for transport across the cell membrane 
(see Introduction). Dipyridamole, DIP, a nucleosid e 
transport inhibitor, abolished the effect of inosine 
on cAMP accumulation. It is likely that inosine 
was taken up by the cells, converted to adenosine 
and expressed the same effects as metabolizable 
adenosine. However, the potentiating effect of 
both NECA and adenosine on FSH-stimulated 
cAMP accumulation was still as demonstrable as 
in the absence of DIP. 
When both ADA and DIP were present 8-PHT 
did not further decrease FSH-stimulated cAMP 
accumulation. Under these conditions the dose-
response curve for NECA was s hifted to the right 
by 8-PHT and it increased the EC50 for NECA 
three-fold (paper III). This suggests a competition 
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between NECA and 8-PHT for the adenosine 
receptor. 
The adenosine analogs S-PIA and R-PIA, are 
known to have lower affinities for the stimulatory 
A2 receptor than for the inhibitory Aj receptor. 
However, these analogs did not potentiate FSH-
stimulated cAMP accumulation. On the contrary, 
both S-PIA and R-PIA inhibited cAMP accumulation 
in granulosa cells. The precursor to S-PIA and 
R-PIA, amphetamine, was also tested and it did 
not elicit inhibitory effects. The inhibitory effect 
of S -PIA was reversible, indicating that the cells 
were still viable and responsive to FSH. These 
results indicate that the effect of PIA analogs 
was not due to irreversible toxicity of the com­
pounds suggesting the presence of inhibitory A^ 
receptors in granulosa cells. However, the effects 
of S -PIA and R-PIA were not antagonized by 8-
PHT. Furthermore, when the cells were incubated 
under more stringent conditions with respect to 
endogenous adenosine, i.e. with DIP and ADA, 
the inhibitory effects of S-PIA and R-PIA on 
FSH-stimulated cAMP accumulation were almost 
completely abolished (paper III). Therefore the 
inhibitory effects are likely to be intracellular 
and not due to Aj receptors. 
Incubation of isolated luteal cells from both 2 
and 5-6 day-old corpora lutea with NECA or S-
PIA alone did not increase cAMP accumulation. 
However, LH-stimulated cAMP accumulation was 
dose-dependently potentiated by N ECA, but not 
by S-PIA. This effect of NECA was slightly 
antagonized by 8-PHT, but not to the same mag­
nitude as in the granulosa cells (paper V). 
A 
I 
adenosine 
analog 
: Az receptor 
- Adenosine increases gonadotropin-induced cAMP 
accumulation 
- Adenosine analogs increases gonadotropin-induced 
cAMP accumulation in granulosa and luteal cells 
with the characteristics of A2 receptor activation 
Effect of adenosine analogs on adenylate cyclase 
activity in membrane preparations from the ovary 
(papers III, IV and V) 
To exclude the possibility that adenosine analog 
effects were a result of direct or indirect intra­
cellular events but rather were a result of m em-
brane-associated events, i.e. adenosine receptor 
activation, adenylate cyclase activity was studied 
in ovarian membranes. The ovarian membranes 
were prepared from ovaries of immature PMS-
treated preovulatory rats (see Methods). NECA (1 
(jiM) s timulated adenylate cyclase both in the ab­
sence and presence of FSH. This stimulating effect 
of NECA, with and without FSH, was decreased 
by 8-PHT (paper III). 
NECA ^"»s-dependently increased the adenylate 
cyclase activity in the ovarian membrane prepara­
tion. The calculated EC50 was found to be 0.28 
U.M. well below that found in granulosa cells. 
NECA additively increased FSH-stimulated adenylate 
cyclase activity over the whole tested dose range 
of FSH (1-1000 ng/ml). Both in the presence and 
absence of FSH, NECA dose-dependently increased 
cAMP production. However, the EC50 for NECA 
in the presence of FSH seemed to be subject to 
greater variations than in the absence of FSH. 
Nevertheless, the EC50 for NECA in membranes 
in the presence of FSH was in the same range 
as without FSH and considerably lower than in 
whole cells. The maximal response to NECA was 
approximately half of the maximal response to 
FSH. However, the absolute response to NECA 
was relatively small (approximately 30% above 
the basal activity for the adenosine analogs) 
and might be explained by the low ATP concentra­
tion (0.1 mM) in the assay system ( for further 
discussion see Methods). 
The adenosine receptor antagonist 8-PHT shifted 
the dose-response curve for NECA to the right 
and increased the EC50 almost 10-fold. Also in 
the presence of FSH the potentiating effect of 
NECA was antagonized by 8-PHT. 
In the ovarian membrane preparation, four 
different adenosine analogs were tested for their 
relative potency on adenylate cyclase activation. 
All four analogs NECA, 2-Clado, R-PIA and S-
PIA stimulated adenylate cyclase activity. NECA 
was found to be the most potent of the four, 
followed by 2-Clado, R-PIA and S-PIA (paper IV). 
In membranes from luteinized ovaries, NECA 
alone was found to stimulate adenylate cyclase 
activity by 30% (see above) and the EC50 for 
NECA was 0.65 |iM. The dose-dependent effect of 
NECA was antagonized by 8-PHT and increased 
the EC50 by one order of magnitude. When the 
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Effect of NECA on FSH-stimulated progesterone production in superfused granulosa cells in the presence and 
absence (right) of adenosine deaminase (left). 
Granulosa cells were superfused for 9h. Medium, 30 p,l/min, was sampled in 15 min fractions. FSH (10 ng/ml) 
was present from fraction 14 to 20 in all superfusions. NECA (open triangles, 100 |xM) was introduced from 
fraction 9 and was present until the end of superfusion. 
The basal secretion was set to 100 %, and was the mean of fraction 1-8, i.e. before addition of NECA. The 
basal secretion in absolute terms was 1.33 ng/fraction/mg protein and 3.31 ng/fraction/mg protein in the absence 
and presence of adenosine deaminase (ADA), respectively. All subsequent values are expressed as percent of 
the basal secretion. The data (mean ± SEM) were pooled from two identical experiments with two superfusions 
for each treatment. 
other adenosine analogs were tested for acloirylate 
cyclase activation NECA was found to be the 
most potent one, with the following order of 
potency NECA > 2-Clado > R-PIA > S-PIA. Also in 
luteal cell homogenates, NECA stimulated the 
adenylate cyclase (EC50 0.53 |xM) and the dose-
response curve was shifted to the right by 8-
PHT (paper V). 
These results suggest the presence of A2 
receptors in luteal cells, ovarian and luteal mem­
branes. 
c A M P f  
cAMP j 
- Adenosine analogs stimulate adenylate cyclase 
in membranes from non-luteinized and luteinized 
ovaries as well as luteal cell homogenate with 
the characteristics of A2 receptor activation 
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Effect of adenosine on steroidogenesis in ovarian 
cell (papers I and V) 
Progesterone production in luteal cells was 
stimulated by NECA. The effect was time-dependent 
and was detectable already after 15 min of incuba­
tion. In LH-stimulated cells, a signifi cant additional 
effect by NECA on progesterone synthesis was 
only seen after longer incubation times (3 h) 
(paper V). 
In granulosa cell incubations the progesterone 
secretion was minutely, but significantly, increased 
in th e presence of adenosine. However, adenosine 
did not significantly affect maximum gonadotropin-
stimulated progesterone secretion, nor did it sig­
nificantly alter the EC50 for FSH (paper I). The 
adenosine analog 2-Clado had no s ignificant change 
in basal and FSH-stimulated progesterone accu­
mulation in granulosa cells (paper I). 
NECA slightly stimulated the progesterone 
synthesis in incubated granulosa cells. However, 
the dose-dependent stimulatory effect of NECA 
on FSH-induced cAMP accumulation in granulosa 
cells was not reflected in progesterone synthesis. 
This finding might imply th at the enhancing effect 
of adenosine analogs on adenylate cyclase activity 
is an in vitro artefact. Alternatively steroidogenesis 
was maximally stimulated by endogenous adenosi ne. 
This possibility is supported by t he finding that 
FSH-stimulated granulosa cells exposed to ADA 
in a superfusion system (Johanson and Johanson, 
1988) responded with higher progesterone production 
in the presence than in the absence of N ECA. In 
the absence of ADA , NECA did not change FSH-
stimulated progesterone production (fig 7). However, 
the cAMP response to NECA was similar in the 
presence and in the absence of AD A. This finding 
indicates that endogenously produced adenosine 
"auto-stimulates" the cells to increase their 
steroidogenic response to a submaximal FSH stim­
ulation. 
This suggests that only a fraction of the 
putative adenosine receptors need to be occupied 
in order to achieve a maximal steroidogenic 
response. 
steroid 
teroid t  
r 
- Adenosine analogs stimulate progesterone 
synthesis in luteal cells and, to some extent, 
in granulosa cells 
- Adenosine analogs potentiate submaximal FSH-
stimulated progesterone synthesis in granulosa 
cells 
Summary of results 
Effects of metabolizable adenosine: 
- Adenosine is taken up into granulosa and luteal 
cells. 
- Adenosine is metabolized and increases cellular 
ATP levels in granulosa cells and cumulus-
oocyte complexes. 
- Extracellular cAMP is metabolized to adenosine 
and increases ATP in granulosa cells. 
- FSH, LH and forskolin decreases granulosa cell 
ATP levels. 
- Adenosine reverses the FSH-induced decrease 
in oxygen consumption in cumulus-oocyte 
complexes. 
- Adenosine decreases lactate formation in 
granulosa cells and cumulus-oocytes complexes. 
- Adenosine increases gonadotropin-induced cAMP 
accumulation. 
Effects of non-metabolizable adenosine analogs: 
- Adenosine analogs do not increase cellular ATP 
levels. 
- Adenosine analogs increase gonadotropin-induced 
cAMP accumulation in granulosa and luteal cells 
with the characteristics of A2 receptor activa­
tion. 
- Adenosine analogs stimulate adenylate cyclase 
in membranes from non-lu teinized and luteinized 
ovaries as well as luteal cell homogenate with 
the characteristics of A2 receptor activation. 
- Adenosine analogs stimulate progesterone 
synthesis in luteal cells and, to some extent, 
in granulosa cells. 
- Adenosine analogs potentiate submaximal FSH-
stimulated progesterone synthesis in granulosa 
cells. 
In conclusion, these results suggest both a role 
of a denosine as intracellular substrate as well as 
agonist to extracellular receptors participating in 
the activation of ovarian adenylate cyclase system. 
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GENERAL DISCUSSION 
Adenosine and adenosine receptors in endocrine 
tissues. 
Adenosine may be a candidate for autocrine/-
paracrine function whereby it acts as a "local 
hormone". However, adenosine is also a substrate 
for cellular metabolism. In some metabo lic pathways 
adenosine is a precursor and in others a product, 
for instance, phosphorylation of adenosine by 
adenosine kinase to AMP and dephosphorylation 
of A MP to adenosine. As a result, adenosine can 
be recirculated within and between adjacent cells. 
For these reason adenosine cannot, according to 
definition (see Introduction), be a classical hormone. 
Classical hormones are degraded and inactivated 
as a part of the regulation of hormone action. In 
the presence of adenosine receptors, adenosine 
may act both as a hormone and as substrate 
depending on its localization, inside or outside 
the cell, and on the metabolic demands of the 
cell. Based on this concept and experimental data, 
authors have proposed a local action for adenosine 
in the gonads: as receptor agonist in the testis 
(Monaco et al, 1984) and via intr acellular action 
in the ovary (Behrman et al., 1986). 
Since the knowledge of adeno sine action in the 
ovary is limited it may b e adequate to broaden 
the perspective to other endocrine tissues where 
adenosine action has been studied, i.e. the pancreas, 
the adrenals, the thyroid and the testis. 
The adrenals, the pancreas and the thyroid 
One of the earliest reports introducing the 
concept of adenosine receptors demonstrated 
stimulatory effects of adenosine in adrenal tumor 
cells, both on cAMP production and steroidog enesis 
(Wolff and Cook, 1977). However, adenosine 
inhibited cAMP and steroid production in adrenal 
cortex cells isolated from non-tumor adrenals. 
ACTH-stimulated cAMP generation and steroido­
genesis was inhibited by adenosine analogs, but 
also dbcAMP-induced steroid production. These 
findings indicated that, in this cell preparation, 
adenosine receptors mediated inhibition both prior 
and subsequent to the adenylate cyclase (Shima, 
1986). These opposing effects of adenosine a nalogs 
in tumor and normal cells was due to the presence 
of different adenosine receptors i.e. A2 and Aj 
receptors in the different cell types. Changes in 
receptor expression induced by tumor transformation 
or in vitro cell culture adaptation has also been 
observed in other tissues like the thyroid and the 
testis (see below). 
When adenosine was administered in vivo, it 
acted synergistically with ACTH on adrenal steroid­
ogenesis (Formento et al. , 1975). Adenosine alone 
stimulated steroid production but this effect was 
prevented by dexamethasone treatment. This 
indicated that the target organ for adenosine 
might b e the pituitary or that adrenal adenosine 
action was markedly po tentiated by low concentra­
tions of A CTH. It could not be concluded from 
the presented data which of t he mechanisms that 
was responsible for the reported results, or if it 
was due to increased substrate availability to 
cAMP, since adenosine analogs were not used in 
the study. Another possible mechanism could involve 
the adenosine-induced vascular changes. 
Adenosine affects the endocrine pancreas in 
a dual mode having both inhibitory and stimulatory 
actions on the secretion of in sulin and glucagon, 
respectively. Adenosine and its analogs inhibited 
glucagon-stimulated adenylate cyclase activity 
and inhibited glucose-stimulated insulin s ecretion 
from islets of Langerhans via Aj receptors (Ismail 
et al., 1977; Schutz et al, 1979). The inhibition 
of insulin release does not seem to involv e changes 
in insulin production or glucose oxidation (Campbell 
and Taylor, 1982). Interestingly, adenosine mediated 
not only decreased insulin secretion but also 
increased glucagon secretion in perfused pancreas 
(Weir et al., 1975; Bacher et al., 1982; Loubatieres-
Mariani et al., 1982; Chapal et al., 1985). Infusion 
of a denosine analogs in vivo increased glucagon 
release but also increased glucose levels and 
decreased FFA levels (Schutz et al., 1978a,b). 
Hyperglycemia and decreased FFA levels are the 
expected results from increased glucagon action, 
although the change in FFA could also be the 
result of adenosine-receptor mediated anti- lipolytic 
action in adipocytes (Fain, 1973; Fredholm, 1978a). 
Effects of adenosine have also been reported 
in the exocrine pancreas. Adenosine and ATP 
alone do not change the exocrine secretion but 
submaximal secretin stimulation was potentiated 
by adenosine and this effect was antagonized by 
theophylline. The potentiating effect of ade nosine 
on secretin-stimulated exocrine secretion was 
claimed to be mediated via A2 receptors (Yamagishi 
et al., 1985, 1986, 1987). Secretin stimulates 
pancreatic exocrine secretion and this effect is 
suggested to be, at least in part, cAMP-mediated 
(Case et al., 1972; Case and Scratchered, 1972). 
Both in adrenal cells and in thyroid cells 
opposing results reg arding adenosine responsiveness 
have been reported in primary cells from normal 
tissue and in cell lines. In normal guinea pig 
thyroid tissue adenosine analogs increased cAMP 
production in a way that was compatible with 
the presence of A2 receptors (Fradkin et al., 
1982), whereas, in a thyroid cell line, inhibitory 
A-[ receptor-mediated effects on TSH-stimulated 
cAMP formation were recently presented (Berman 
et al., 1986). 
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Table 6 
Adenosine receptor mediated effects In endocrine t issue and Inte raction with hormone ac tion In endocrine ta rget tissue 
Al receptors 
Tissue species preparation assay analog IC50 Author year 
pituitary cell line eel 1 GH secretion PIA 30nH Dor fl Inger ond Schonbrunn 1985 
pituitary cell line eel I GH secretion ado •6-3uH Dorf linger and Sc honbrunn 1985 
Islets of Langerhans rat membrane AC ado •<0.IuM ismall et al 1977 
Islets of Langerhans rat cell Inhib Insulin secretion ado *<10uM Ismail et al 1977 
Islets of Langerhans rat cell inhib Insulin secretion NECA 0.1-10uM Schutz et al 1979 
Islets of Langerhans rat cell CAMP ado *<10uH Canpbell and Taylor 1982 
Islets of Langerhans rat cell CAMP PIA •<10uM Canpbell and Taylor 1982 
Islets of Langerhans rat cell Inhib Insulin secretion ado l-10uM Campbell and Taylor 1982 
Islets of Langerhans rat eel 1 Inhib Insulin secretion PIA O.luM Canpbell and Taylor 1982 
pancreas dog perfused tn vivo Inhib insulin secretion KECA •<lnM Bacher e t al 1982 
pancreas dog perfused In vivo stim Insulin secretion HECA •»O.luM Bacher e t al 1982 
thyroid cell line rat eel 1 CAMP PIA 0.5nM Berman et al 1986 
thyroid cell line rat mentirane binding CKA 0.5nH Berman et al 1986 
Sertoli cells rat membrane binding C HA 2.1nM Monaco et al 1984 
Sertoli cells rat eel i cAMP PIA+FSH 2.1nH Monaco et al 1984 
Sertoli cells rat cell Inhib estogen accunula tlon PIA+FSH 3.1nM Monaco et al 1984 
Sertoli cells rat cell cAJIP PIA 0.5-lnM Eikvar et al 1985 
Sertoli cells rat eel 1 cAMP PIA Monaco e t al 1986 
adrenal cortex cells rat cell inhib of steroidogenesis PIA 2-5nM Shima 1986 
adrenal corte x cells rat metrbrane AC PIA 13-64nM Shlma 1986 
hepatocytes rat cell preventing glucagon in hib PIA 6nM ' Wallace et al 1984 
of insulin Induced POE 
hepatocytes rat cell Inhib of glucagon Induced PIA* 4nM Wallace et al 1984 
desensltization of AC insulin 
A2 receptors 
Tissue species preparation assay analog ED50 Author year 
luteal cells rat cells cAHP adotLH 22uM Hall et al 1981 
granulosa c ells rat cells cAMP HECAtFSH 40 uM Paper I II 1988 
ovary rat menfcrane AC HECA 0.28uM Paper IV 1988 
luteinized ovary rat membrane AC HECA 0.65uH Paper V 1988 
luteal cells rat cell homogenate AC NECA 0.59uM Paper V 1988 
Leydig tumo r cells membrane AC Clado 8uM Londos and Wolff 1977 
Leydig tumor ce lls membrane AC PIA 40uM Londos and Wolff 1977 
Leydig tumor ce lls 1-10 membrane AC Clado lO-lOOuM Wolff and C ook 1977 
Leydig tumor ce lls 1-10 membrane AC HECA l-10uM Londos et al 1980 
Leydig tumor ce lls 1-10 cells 20a-dlhydroprogesterone HECA 10-100nM Londos et al 1980 
Leydig ce lls rat cell st Im steroid production PIA 50uH Rommerts e t al 1984 
Leydig tumo r cells cells cAMP ado»LH luH Dix et al 1985 
Leydig tumo r c ells cells cAHP PIA+LH •<10uM Dix et al 1985 
Adrenal tumor c ells Y-l cells 20a-d thydroprogesterone HECA 100 nM Londos et al 1980 
Adrenal tumor c ells Y-l membrane AC Clado lO-lOOuM Wolff and C ook 1977 
thyroid tissue porcine pieces cAMP HECA 0.7uM Fradkln et al 1982 
pancreas dog perfused tn vivo stim glucagon sec retion HECA *<lnM Bacher e t al 1982 
pancreas rat perfused In vitro stim glucagon sec retion HECA 40nM Chapal et al 1985 
•significant effect 
ED50 or IC50 not determined 
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The testis 
In the testis several aspects of adenosine 
receptor action have been documented. Crude 
homogenates of t estis and brain exhibit the highest 
binding capacity for Aj receptor agonist of all 
organs tested (Williams and Risley, 1980; Murphy 
and Snyder, 1981). In the testis adenosine receptor 
binding or activation has been claimed to be 
associated with spermatocytes, Leydig cells and 
Sertoli cells and some controversy exists as to 
what testicular cell type the physiological action 
of adenosine should be attributed. 
Binding of adenosine appeared to be associated 
with the spermatocytes within the seminiferous 
tubule epithelium (Murphy et al., 1983). However, 
binding to Sertoli cells with the characteristics 
of Aj_ receptors has convincingly been demon­
strated (Monaco et al., 1984; Monaco and Conti, 
1986). Furthermore, the binding capacity, not the 
affinity, of adenos ine Aj agonist increased markedly 
in rat testis up to 60 days of age (Monaco and 
Conti, 1986). Testosterone treatment, which suppres­
ses LH secretion in intact animals, did not affect 
adenosine receptor binding. However, hypophysec-
tomy decreased total binding to rat testis (Murphy 
et al., 1983), indicating that testicular adenosine 
receptors needed gonadotropin support, most likely 
FSH (Baker et al., 1976). 
The functional response of adenosine agonists 
in the normal testis suggests the presence of an 
Ai receptor. In Sertoli cells FSH-stimulated 
adenylate cyclase activity was inhibited by adeno­
sine analogs and so was FSH-stimulated androgen 
aromatization (Monaco et al., 1984; Monaco and 
Conti, 1986). Other agents stimulating Sertoli cell 
adenylate cyclase were also inhibited by adeno­
sine (Monaco et al., 1984; Eikvar et al., 1985). 
However, when androgen aromatization was stimu­
lated by dbcAMP, adenosine agonists were not 
inhibitory (Monaco et al 1984) in contrast to the 
demonstrated A.\ receptor-mediated inhibition of 
dbcAMP-stimulated steroidogenesis in normal 
adrenocortical cells (Shima, 1986). 
In early reports, adenosine agonists were shown 
to stimulate adenosine receptor-mediated adenylate 
cyclase activity in a Leydig tumor cell line and 
these results were used as part of the basis for 
the definition of A2 adenosine receptors (Londos 
and Wolff, 1977; Wolff a nd Cook, 1977). A2 recep­
tors do not seem to be present in the normal 
testis (Murhpy et al 1983; Monaco et al., 1984; 
Eikvar et al., 1985; Monaco and Conti, 1986). 
However, it has been reported that normal Leydig 
cells developed responsiveness to adenosine during 
culture and the authors suggested that this A2 
adenosine receptor was a result of i n vitro condi­
tions (Rommerts et al., 1984). 
A plausible physiological role for adenosine 
receptor-mediated effects has been presented. It 
was suggested that Sertoli cell adenosine receptors 
were part of in tercellular communication between 
the Sertoli and germ cells whereby Sertoli cells 
monitored the energy balance in germ cells by 
sensing adenosine, the ATP catalyzate, released 
from the germ cells (Monaco and Conti, 1986). 
Some of the characteristics of adenosine 
receptors in endocrine tissue are summarized in 
table 6. 
Adenosine as substrate and receptor agonist in the 
ovary 
In the gonads, adenosine has been suggested 
to exert local action; extracellularly in the testis 
as a receptor agonist (Monaco et al, 1984) and 
intracellularly in the ovary as a substrate (Behrman 
et al., 1982, 1986b). If the action of adenosine in 
the ovary is autocrine/paracrine then: 
1) adenosine has to induce metabolic or other 
effects in neighboring cells or in the adenosine 
releasing cell itself 
2) adenosine has to be produced and released by 
ovarian cells 
3) the ovarian cells must have a regulatory mecha­
nism for the production, release and/or response 
to adenosine. 
These features may not be shared by all ovarian 
cells. From a regulatory point of view, it is perhaps 
more likely that they are not shared by all cells 
if a local and/or autocrine/paracrine regulatory 
role exists in the ovary. 
Before addressing the question of a possible 
physiological autocrine/paracrine role for adenosine 
in ovarian tissue, the possible cellular effects, 
production, release and regulation of adenosine 
have to be discussed. 
Adenosine augmentation of adenylate cyclase 
activity and cAMP generation in ovarian cells 
Adenosine and its analogs dose-dependently 
stimulated basal cAMP accumulation and potentiated 
gonadotropin-stimulated cAMP accumulation in 
granulosa cells (Polan et al., 1983; Ohkawa et al., 
1985; papers I and III), in cumulus-oocyte complexes 
(Preston et al., 1987) and in luteal cells (Hall et 
al., 1981; Brennan et al., 1983; Behrman et al., 
1983b; Sender Baum and Ahrén, 1986a; paper V). 
However, the stimulation by adenosine or its 
analogs alone in ovarian cells was quantitatively 
small compared to the augmenting effect on 
gonadotropin-stimulated adenylate cyclase in 
granulosa cells, in luteal cells and also in Leydig 
cells (Dix et al., 1985) similar to adenosine poten­
tiation of the secretin-stimulated secretion from 
the exocrine pancreas (Yamagishi et al., 1985, 
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1986,1987). 
Adenosine may increase cAMP in two principally 
different ways, either by increasing substrate 
availability to adenylate cyclase or by stimulating 
adenylate cyclase through adenosine receptors. 
From experiments where adenosine uptake was 
inhibited by DIP, Behrman and coworkers (Hall 
et al., 1981) concluded that the potentiating effect 
of m etabolizable adenosine on LH-induced cAMP 
accumulation in luteal cells was mainly (80%) due 
to intracellular and to a minor degree (20%) due 
to extracellular events. Furthermore, they concluded 
that the predominant effect of adenosine on 
gonadotropin-induced cAMP accumulation in 
granulosa cells was intracellular and that "the 
action of adenine-derived purines was shown to 
be linked to an increase in granulosa cell ATP 
levels" (Ohkawa et al., 1985). This suggested that 
adenosine acted as a substrate. However, in the 
same paper they it was shown that the nucleo­
side transport inhibitor, DIP, blocked adenosine-
induced ATP increase, while adenosine still dose-
dependently increased FSH-stimulated cAMP 
accumulation to 80% of that in the absence of 
DIP (Ohkawa et al., 1985). In a similar experiment 
with granulosa cells, we confirmed this result. 
While DIP (10 |xM) inhibited 90% of the adenosine 
(50 |j,M) uptake adenosine potentiated cAMP ac­
cumulation in the FSH-stimulated cells to 60-
75% of the levels reached in the absence of D IP. 
Furthermore, NECA in combination with FSH 
stimulated cAMP both in the presence and absence 
of DIP. However, DIP alone seemed to have an 
inhibitory effect on FSH-induced cAMP accumula­
tion and it was decreased to approximately the 
same extent both in the presence and absence of 
adenosine and NECA (paper III). This may represent 
non-specific effects of D IP but it may also be that 
DIP inhibited uptake of en dogenous or exogenous 
adenosine to an extent that decreased or partially 
impaired the intracellular nucleoside metabolism. 
Considering the papers discussed above, it seems 
justified to modify the statement that the predo­
minant site of action for adenosine is intracel­
lular (Hall et al., 1981; Ohkawa et al., 1985), at 
least for granulosa cells. 
The effects of adenosine in the presence of 
DIP suggested an extracellular site of action. 
Furthermore, since NECA presumably was not 
metabolized in ovarian cells (paper I), the effects 
of the analog indicated a non-substrate effect. 
These indications suggest an extracellular non-
substrate action of adenosine, possibly receptor-
mediated. If adenosine receptors of the stimulatory 
A2 subtype are involved then the ade nosine receptor 
antagonists should reverse the effect or diminish 
it. The order of potency for the utilized adenosine 
analogs should be NECA>2-Clado>R-PIA>S-PIA 
and the EC50 for NECA should be in the low 
micromolar range (see Introduction). 
As with adenosine alone, NECA stimulated 
basal cAMP production only slightly in granulosa 
(paper III) and luteal cells (paper V). However, 
NECA stimulated gonadotropin-induced cAMP 
accumulation much more prominently (paper III 
and V). Similar findings have been presented for 
Leydig cells (Dix et al, 1985). The EC50 for NECA 
in FSH-induced cAMP accumulation was around 
40 (JLM in granulosa cells which was in the same 
magnitude as for adenosine (paper III). Similar 
results have been reported for adenosine in Un­
stimulated luteal cells where the EC50 was repor­
ted to be 22 |AM (Hal l et al. 1981). The stimulatory 
effect of NECA on cAMP accumulation was an­
tagonized by the receptor antagonist 8-PHT in 
FSH-stimulated granulosa cells (paper III) and, to 
a lesser degree, in LH-stimulated luteal cells (paper 
V). 
The EC50 values presented above are at least 
one order of m agnitude higher than those reported 
for most other cells with A2 receptors (Londos 
et al, 1981; Daly, 1983). It may for this reason 
be questioned whether the effect of NECA was 
mediated via an adenosine receptor, as it has 
been described in other cells, in spite of the 
fact that 8-PHT displaced the dose-response curve 
to the right, at least in granulosa cells, and the 
other adenosine analog, 2-Clado, showed similar 
stimulatory characteristics as NECA and adenosine 
(paper III). 
In three different membrane preparations 
obtained from preovulatory ovaries from PMSG-
treated immature rats, luteinized ovaries and 
luteal cells, NECA alone stimulated adenylate 
cyclase activity. The EC50 values for NECA in 
these preparations were found to be lower (0.28-
0.65 |xM) than in granulosa cells and more in the 
expected range for an A2 receptor. The effect of 
NECA was antagonized by 8-PHT and other xan­
thines. The order of p otency for adenosine analogs 
was found to be that of an A2 receptor, i.e. 
NECA > 2-Clado > R-PIA > S-PIA (papers HI, IV and 
V). However, the maximal stimulatory effect of 
NECA was rather limited, only 30% over basal 
activity and half that of maximal FSH stimulation 
(paper III and IV). This limited response may be 
due to an intrinsic limitation of the energy 
regenerating system in the assay (see Results 
and Comments). 
If the criteria for an A2 receptor were not 
fulfilled with whole cells, the data from the 
experiments on membrane preparations strongly 
suggested the presence of A2 receptors. However, 
still some results reside un-explained. Why were 
the EC50 values so much higher in the cells than 
in membranes? Why do not the analogs alone 
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stimulate cAMP in the cells as well as they stimula­
te of adenylate cyclase activity in the membranes? 
It is not easy to give a satisfactory explanation 
to this but with insufficient data only speculation 
remains. One explanation may be that endoge nously 
produced adenosine was present in whole cells 
and displaced NECA from the putative receptor. 
This explanation is not very likely since approx­
imately the same EC50 value for NECA was found 
in incubated granulosa cells the absence and in 
the presence of ADA in combination with FSH. 
However, in granulosa cell superfusion experiments 
NECA augmented FSH-stimulated steroidogenesis 
in the presence of ADA (see Results and Comments). 
Another suggestion could be that NECA inter­
fered with nucleoside transport into cells and, 
hence, directly or indirectly interfered with the 
intracellular adenosine metabolism. In support of 
this was the fact that DIP, a nucleoside trans­
port inhibitor, also decreased cAMP accumula­
tion and, to some extent, also ATP formation in 
granulosa cells (paper III). In Leydig tumor cells 
adenosine and its analogs potentiated LH-induced 
cAMP accumulation, while adenosine inhibited 
LH-induced desensitization of adenylate cyclase. 
The effects of adenosine were shown to have the 
characteristics of A2 receptor activation. How­
ever, adenosine alone did not affect cAMP levels 
(Dix et al., 1985). The authors suggested that 
adenosine has potentiating effects through an 
action at or proximally to the G-protein in LH-
stimulated adenylate cyclase. The G-protein is a 
membrane protein that mediates the stimulation 
between the LH-receptor and the adenylate cyc­
lase (see Introduction). A similar non-adenylate 
cyclase stimulatory or inhib itory action of adenosi ne 
has been reported in hepatocytes (Wallace et al., 
1984). Adenosine in these cells, without affecting 
adenylate cyclase alone, abolished the effect of 
glucagon in blocking insulin activation of PDE 
and glucagon desensitization of adenylate cyclase 
activity. 
In spite of the short-comings mentioned above, 
the data suggest the presence of A2 receptors in 
granulosa and luteal cells. However, it is perhaps 
wrong to phrase the question whether the action 
of adenosine is extracellular or intracellular. 
Instead one should ask whether the extracellular 
receptor-mediated and the intracellular substrate 
actions of adenosine are related to each other 
and cooperate in the cell. 
Steroidogenesis in relation to adenosine in ovarian 
cells. 
Adenosine stimulated basal progesterone synthesis 
in human and rat granulosa cells (Polan et al., 
1983; paper I) and luteal cells (Hall et al., 1981; 
Polan et al., 1983). Also the adenosine analog 
NECA markedly stimulated the progesterone 
synthesis in luteal cells (paper V). The stimulatory 
effect of a denosine and its analogs on steroido­
genesis was limited and not in concordance to 
the cAMP response, especially not the adenosine 
augmentation of gonadotropin stimulated cAMP 
accumulation (papers I, III, V). 
It might be that the lack of concordance 
between the marked increase in cAMP and the 
very lim ited increase in progesterone from gon-
adotropin-stimulated ovarian cells is an in vitro 
artifact or that not the correct functional para­
meter was mon itored for the adenosine receptor-
mediated response. An alternative suggestion is 
that endogenous adenosine may occupy a fraction 
of adenosine receptors, small but sufficient for 
maximal steroidogenic response. In favour of the 
latter suggestion is the finding that, in superfused 
granulosa cells where adenosine was removed 
with ADA, NECA potentiated FSH-stimulated 
progesterone production (see Results and Comments). 
Effects of adenosine on glycolysis and oxygen 
consumption in ovarian cells. 
The preovulatory follicle has a high glycolytic 
capacity (Nilsson, 1974; Hillensjö, 1976; Tsafriri 
et al., 1976a) and lactate accumulation is high in 
gonadotropin stimulated granulosa cells (Billig et 
al., 1983; Hillier et al., 1985). The lactate accumula­
tion occurred during incubation in atmospheric 
oxygen concentrations and is not likely to be 
due to decreased oxygen availability (Billig et al., 
1983, 1984). Despite increased metabolic activity, 
gonadotropins decreased the oxygen consumption 
in cumulus-oocyte complexes (Hillensjö et al 1975; 
Dekel et al, 1976; Magnusson and Hillensjö, 1981). 
The increased lactate accumulation may indi cate 
a decreased rate of pyruvate entering the citric 
acid cycle (see Introduction). The concomitant 
decreased oxygen utilization suggests that the 
increased lactate accumulation is not due to a 
lack of available oxygen. 
It has been suggested from our laboratory 
(Hillensjö, 1976; Dekel et al., 1976; pap^r II) that 
the decreased oxygen consumption in cumulus-oocyte 
complexes is due to a competition for a limited 
quantity of c ofactors in common for both glyco­
lysis and oxidative phosphorylation. This mechanism 
was proposed several decades ago (Belitzer, 1936) 
to be the cause of decreased oxygen consumption 
after addition of glucose to certain tumor cells 
(Crabtree, 1929). It has been suggested that a 
relative lack of ADP (Ibsen, 1961) or inorganic 
phosphate (Koobs, 1972) would be limiting factors 
for the decreased rate in the respiratory chain 
with concomitant decreased oxygen consumption 
and increased lactate formation. 
Addition of metabolizable adenosine abolished 
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the gonadotropin-induced decrease in oxygen 
consumption in cumulus-oocyte complexes. Lactate 
accumulation also decreased, while ATP levels 
increased (paper II). Addition of adenosine to 
granulosa cells also decreased lactate accumulation 
(see Results and Comments) and increased ATP 
formation (Ohkawa et al, 1985; paper I). The 
results suggest that, in both gonadotropin-stimu-
lated cumulus-oocyte complexes and granulosa 
cells, adenosine increased the activity in the 
respiratory chain leading to increased rate of 
pyruvate entering the citric acid cycle, while 
lactate accumulation decreased. However, it has 
been suggested that lactate production is important 
for the oocyte, since it cannot utilize glucose as 
energy substrate but requires lactate and pyruvate 
(Biggers et al., 1967; Kennedy and Donahue, 1969; 
Zeilmaker et al., 1974). In analogy, in the testis 
Sertoli cells produce lactate (Robinson and Fritz, 
1981) and the production is stimulated by FSH 
(Mita et al., 1982; LeGac et al., 1983). Testis germ 
cells can be supported with lactate, but not glucose 
(Jutte et al., 1981; Robinson and Fritz, 1981) and 
oxygen consumption increase in isolated germ 
cells after addition of l actate (Robinson and Fritz, 
1981). 
Relatively low concentrations of adenosine, 0.5 
|xM, abolished the FSH-induced decrease in oxygen 
consumption in cumulus-oocyte complexes. As 
will be argued below, the adenosine levels may 
well be 0.5 |j,M or higher in the cumulus-oocyte 
complex. Consequently, the physiological relevance 
of the decreased respiration and perhaps also the 
increased lactate accumulation in the presence of 
gonadotropins may be questioned. However, FSH 
decreased ATP levels (paper II) and is likely to 
increase the efflux of adenosine from the cumulus-
oocyte complexes, this in turn decreasing the 
uptake of adenosine, as in granulosa cells (paper 
I). FSH-stimulated adenylate cyclase and other 
ATP-requiring enzyme reactions thereby increased 
the ATP consumption and the demand on ATP 
production. Thus, the glycolytic activity has to 
be increased, especially since the activity in the 
respiratory chain is restricted, to meet the demands 
for ATP. This may imply that the increased lactate 
formation is physiological and the decreased oxygen 
consumption is an in vitro result, since sufficient 
adenosine to normalize the'respiration may be 
present in vivo but not in vitro due to relatively 
larger extracellular space (e.g. volume of incu bation 
medium). The lactate concentration being 5-6 
times higher in the rat preovulatory follicle than 
in the serum (Zeilmaker and Verhamme, 1977) 
supports this contention. 
The results support the hypothesis that a 
relative lack of cofactors (i.e. ADP) common for 
both glycolysis and the respiratory chain causes 
the gonadotropin-induced decrease in oxygen 
consumption and increase in lactate accumulation 
in cumulus-oocyte complexes. In this regard, it 
has been reported that ADP was more abundant 
than AMP and ATP after addition of adenosine 
to cumulus-oocyte complexes (Downs et al., 1986a) 
and to luteal cells (Behrman et aL, 1983b). 
As mentioned above gonadotropins increased 
lactate accumulation and decreased ATP levels in 
granulosa cells, while adenosine had the opposite 
effects as in cumulus-oocyte complexes. There is 
a lack of data on granulosa cell respiration from 
the same experimental model from which these data 
were derived and if t he same metabolic restriction 
reside in granulosa cells as in cumulus-oocyte 
complexes remains an open question. However, under 
certain experimental conditions LH-stimulated 
granulosa cells from prepubertal rat ovaries 
increased the oxygen consumption in the presence 
of succinate in hypotonic medium (Hamberger, 
1968). 
Adenosine and oocyte maturation 
The meiotic division of the oocyte is arrested 
during follicular development and this has to be 
completed prior to fertilization. In vivo, the oocyte 
resumes meiotic division prior to ovulation, which 
is after the stimulatory mid-cycle LH/FSH peak 
(Lindner et al., 1974). The meiotic division also 
occurs spontaneously when the oocyte is isolated 
from the follicle (Pincus and Enzmann, 1935). In 
vitro oocyte maturation (i.e. meiotic division) is 
prevented or retarded by agents that increase or 
maintain cAMP levels within the cumulus-oocyte 
complex (Cho et al., 1974; Magnusson and Hillen-
sjö, 1977; Hillensjö et al., 1978; Dekel et al., 
1984; Ekholm et al., 1984; Törnell et al.,1984; Hanski 
and Dekel, 1987) and a decrease in oocyte cAMP 
levels precedes oocyte maturation (Schultz et al., 
1983; Vivarelli et al., 1983). Also, follicular fluid 
and follicular fluid components inhibit spontaneous 
maturation (Chang, 1955; Tsafriri and Channing, 
1975; Tsafriri et al., 1976b). In this context, it is 
interesting to note that one group has suggested 
hypoxanthine to be the principal active component 
in an inhibitory fraction of follicular fluid. The 
concentrations of hypoxanthine were remarkably 
high, in the milli-molar range (Downs et al., 
1985; Eppig et al., 1985). 
Purines inhibit spontaneous oocyte maturation 
and the inhibition is potentiated by cAMP and 
cAMP-inducing substances. Guanosine is the most 
potent of the purines (Downs et al., 1985; Billig 
et al., 1985). Eppig and coworkers have elegantly 
shown that the effect of hypoxanthine and guano­
sine could be attributed to derivatives of these 
purines, xanthyl and/or guanyl compounds (Downs 
et al., 1986a,b; Downs and Eppig, 1987). 
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Adenosine in combination with other purines or 
FSH also inhibit spontaneous oocyte maturation 
(Eppig et al., 1985; Downs et al., 1986a; Miller 
and Behrman, 1986; Petrungaro et al., 1986; Billig 
et al., 1985). At least three principally different 
mechanisms could be suggested for the inhibitory 
action of aden osine on spontaneous oocyte matura­
tion: 1) adenosine being a precursor to xanthyl/ 
guanyl compounds (see above), 2) increased cAMP 
levels caused by increased substrate availability 
to adenylate cyclase and 3) increased cAMP levels 
caused by stimulation of adenosine receptors. 
The first possibility is described above. High 
levels of aden osine (0.1-1 mM) is probably needed 
for it to be the sole contributor of this effect. 
Adenosine, in combination with FSH, increases 
cAMP levels in cumulus-oocyte complexes (Preston 
et al, 1987). However, the inhibitory effect of 
adenosine is as effectively elicited by 2-Clado in 
combination with hypoxanthine (Downs et al., 
1986) or FSH (Miller and Behrman, 1986) sug­
gesting a non-substrate receptor-mediated mecha­
nism for adenosine in oocyte maturation. Adenosine 
receptor-mediated inhibition of Ca ^ + fluxes have 
been described in a number of different tissues 
(Schräder et al., 1975; Phillis and Barraco, 1985; 
Silinsky, 1986; Riberio and Sebastiao, 1986) and 
it has also been suggested that the inhibitory 
effect of adenosine on oocyte maturation could 
be ascribed to decreased mobilization of Ca ^ + . 
Ionophore reversed the inhibitory effect of FSH -
inhibited on spontaneous oocyte maturation in 
isolated cumulus-enclosed oocytes and in the 
presence of adenosine the effect of ionophore 
was counteracted (Preston et al., 1987). However, 
the role of Ca^ + in the initiation of oocyte 
maturation is far from settled (Tsafriri et al, 1988). 
Origin and regulation of ovarian adenosine 
Adenosine exerts a number of differ ent effects 
in ovarian tissue but, to meet the requirements 
for establishing an autocrine/paracrine action, a 
local regulation of adenosine metabolism, uptake 
and release must exist. 
Adenosine metabolism in ovarian cells 
Adenosine increases the ATP level in luteal 
cells (Behrman et al., 1983a, b; Brennan et al., 
1983; Sender Baum and Billig, 1986), in granulosa 
cells (Knecht et al., 1984; Ohkawa et al., 1985; 
paper I) and in cumulus-oocyte complexes (paper 
II). In luteal cells, 90% of the added adenosine 
was phosphorylated within 15 min to AMP, ADP 
and ATP. However, most of the adenosine was 
found as ADP and AMP in luteal cells ( Behrman 
et al., 1983b), instead of ATP (Pearson et al., 
1978). In contrast to luteal cells, where the ATP 
level rapidly reached a maximum 15 min after 
addition of adenosine, maximum levels i n granu­
losa cells were reached after a longer incubation 
period (60 min, Ohkawa et al., 1985; 225 min, 
paper I). 
The ATP content in granulosa cells was d ose-
dependently decreased by FSH (paper I). This 
was even more evident when the cells were co-
incubated with adenosine (Ohkawa et al., 1985; 
paper I). The same phenomenon was also seen 
with cumulus-oocyte complexes (paper II). LH 
also decreased the ATP level in prepubertal ovaries 
(Ahrén et al., 1968), in luteal cells isolated from 
young postovulatory corpora lutea (Sender Baum 
and Billig, 1986), in luteinized ovaries in vivo 
(Soodak et al., 1988) and in incubated granulosa 
cells (paper I) but not in cells isolated from corpora 
lutea from mid-luteal phase (Sender Baum and 
Billig, 1986; Soodak et al., 1988). Forskolin also 
decreased ATP levels in granulo sa cells (see Results 
and Comments). Ohkawa and coworkers (1985), 
on the other hand, reported that LH did not 
decrease ATP levels in granulosa cells. This 
discrepancy may b e due to the different animal 
models used in the two pape rs, hypophysectomized 
estradiol- and FSH-treated rats being used in the 
latter report and PMS-treated in the former, 
since LH receptors may be less developed in 
estradiol-FSH-treated rats (Richards et al., 1979; 
Richards, 1980). 
The FSH-induced decrease of ATP levels in 
granulosa cells was not only due to a diminished 
uptake of aden osine since FSH acutely decreased 
ATP levels in adenosine-preincubated cells. Further­
more, in granulosa cells incubated in the absence 
of adenosine FSH still decreased ATP levels. 
Uptake of adenosine by ovarian cells 
Adenosine is transported into granulosa cells 
(paper I and III), cumulus-oocyte complexes (Heller 
and Schultz, 1980; Downs et al., 1986a) and luteal 
cells (Behrman et al., 1983; paper I). Behrman 
and coworkers (1983b) r eported a K™ of 7.3 |xM 
and a Vmax of about 2 pmol/min/l(P luteal cells 
at 24 C. With a Qjq of 2.9 (Behrman et al., 1983b) 
the Vmax will be about 6 pmol/min/10-' luteal 
cells at 37 C. Although we r eported a lower Vmax 
of 4 pmol/min/10^ luteal cells (paper I), the Vmax 
in luteal cells was markedly higher than in granu­
losa cells, where it was found to be 1.6 pmol/mi-
n/lO^ cells while the Km was 15.9 pM (paper I). 
It is also of in terest to note that FSH decreased 
both the maximal uptake of adenosine and also 
to some extent its tj/2 f°r uptake (paper I). In 
contrast, LH-does not affect adenosine uptake in 
luteal cells (Behrman et al, 1983b). 
The uptake of adenosine is most lik ely regulated, 
not by a limitation of the transmembrane transport, 
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as such, but rather by the intracellular activity 
of adenosine kinase and adenosine deaminase 
and, hence, by the intracellular concentration of 
adenosine which is likely to be very low due to 
metabolism as in other cell types (Arch and 
Newsholme, 1978). If this assumption is valid also 
for ovarian cells, then, judging by the reported 
data on adenosine uptake, there seems to be a 
difference in the intracellular metabolism of 
adenosine in granulosa and luteal cells. 
Origin and putative release of ovarian adenosine 
Extracellular adenosine in the ovary may have 
different origins (see also Introduction): 
1) the general circulation 
2) ovarian cells 
a) released as co-transmitter from nerves 
b) released as adenosine/AMP as a result 
of hypoxia 
c) released as adenosine/AMP as a result 
of decreased levels of cellular ATP 
not due to hypoxia 
d) released as cAMP/AMP 
The blood is the probable source for purine 
homeostasis and for purines required in tissue 
metabolism (Murray et al., 1970). However, it i s 
not likely that the blood concentration of a deno­
sine, under normal physiological conditions, would 
be the regulating factor for adenosine related 
effects in the ovary since changes in adenosine 
levels in the blood do not correlate to ovarian 
function (deSanchez et al., 1983). However, dur­
ing a period of general hypoxia the adenosine 
levels in blood are likely to be increased in the 
ovary as well as all other parts of the body. 
The ovary is, of co urse, innervated (Stefansson 
et al., 1981) and catecholamines affect luteal 
function (Selstam et al., 1987). No evidence of 
adenosine/ATP release from nerve endings in the 
ovary has been presented. If this was the case, 
however, this would give a highly selective increase 
of adenosine in the ovarian compartments. 
Adenosine release as a result of hypoxia is a 
well established mechanism (see Introduction). 
Behrman and coworkers (Ohkawa et al., 1985; 
Behrman et al., 1986) have suggested that the 
granulosa cells may be exposed to relatively high 
concentrations of adenosine caused by hypoxia, 
residing as they are in an avascular area of the 
follicle with the distance to oxygenating blood 
being relatively large. This suggestion is in analogy 
with adenosine action in vessels, although the 
explanations for the decreased oxygen tension 
required for increase of adenosine efflux differs. 
In the coronary vessels the explanation is meta­
bolic and in the ovarian follicle it is morpho­
logical. If the oxygen tension is low in the fol­
licle, then it is probably at the same low level over 
many hours or even days. The low oxygen tension 
is most likely not subject to sudden changes if it 
is explained by the distance to blood vessels and 
this distance is a function of follicular development 
and growth. 
It has to be stressed that the increased efflux 
of adenosine is due to changes in oxygen t ension. 
When the oxidative phosphorylating activity in 
the respiratory chain decreases, due to a relative 
oxygen shortage, the relative amount of AMP 
and ADP increases, resulting in an increased ef­
flux of AMP and adenosine (Arch and Newsholme, 
1978). If the lower oxygen tension is sustained 
over a period of time, as assumed in the follicle, 
then adenosine would not be subject to re-uptake, 
since the uptake is regulated by the intracellular 
metabolism (adenosine kinase and ADA, for refe­
rence see Introduction). Considering this, a more 
likely scenario is that, when a new and sustained 
level of oxygen tension is at hand, this will also 
result in a new and sustained steady state of 
adenosine turnover. The excessive extracellular 
adenosine, due to a previous change in oxygen 
tension, is likely to be transported by diffusion 
from that particular part of tissue or degraded 
by deamination and further metabolized to hypo-
xanthine before transportation from the tissue. 
Based on these assumptions, the adenosine level 
is not likely to be increased in the follicle or 
newly formed corpus luteum due to low vascular­
ization, even though the oxygen tension may be 
low, but sustained. Furthermore, the oxygen tension 
in follicular fluid has been reported to be as high 
as in venous blood (Shalgi et al., 1972). 
The high lactate concentration in follicular 
fluid (Zeilmaker and Verhamme, 1977) may intuitive­
ly indicate carbohydrate metabolism in low oxygen 
tension. However, incubated follicular cells do 
produce a considerable amount of l actate even in 
atmospheric oxygen tension (Billig et al., 1983, 
1984). The lactate production may reflect, instead, 
a specialized metabolism adapted to the environmen­
tal requirements and substrate demands of the 
oocyte, as discussed above. Nevertheless, the low 
vascularization of the follicle may maintain a 
given adenosine level in the extracellular space 
as a result of the low transport capacity of 
adenosine and its metabolites from the ovarian 
compartment. 
Yet another hypothetical mechanism for adeno­
sine release in the ovary may be considered. A 
decrease in cellular ATP will increase AMP con­
centrations and, in the presence of 5'-nucleotidase, 
also adenosine (Arch and Newsholme, 1978). 
Gonadotropins decreased both basal (Ahrén et al., 
1968, paper I, II) and adenosine-augmented ATP 
levels (Ohkawa et al., 1985; Sender Baum and 
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Billig, 1986; paper I,II) in prepubertal ovaries, 
follicular cells and luteal cells from young corpora 
lutea. This decrease in ATP levels may be due to 
increased consumption of ATP, but perhaps also 
to a decreased re-phosphorylation (paper I); both 
are mechanisms that would increase AMP and 
lead to an increased release of adenosine/AMP. 
Cyclic AMP turnover also consumes ATP and 
produces AMP by adenylate cyclase and PDE ac­
tion, respectively. In this context it is interesting 
to recapitulate that FSH decreased the uptake of 
adenosine, decreased ATP levels, increased lactate 
accumulation and decreased oxygen consumption 
in follicular cells (Dekel et al., 1976; Magnusson 
and Hillensjö, 1981; Billig et al 1983; Ohkawa et 
al., 1985; paper I and II). The data suggest a 
decreased propulsion and a re-localization of 
adenosine in gonadotropin-stimulated follicular 
cells that indirectly would increase the extracellular 
adenosine concentration due to decreased uptake 
or increased release. 
The prerequisites for extracellular adenosine 
formation from cAMP are that cAMP has to be 
produced, released and degraded in ovarian cells. 
Furthermore, the enzymes responsible for degrada­
tion of cAMP to adenosine (i.e. PDE and 5'-nucleo-
tidase) have to be present in the same compart­
ment as the cAMP. 
Egress of cAMP is well established in a multi­
tude of tissues and has been suggested to be 
carrier-mediated. Furthermore, cAMP as such is 
not subject to re-uptake through intact cell 
membranes before degradation to adenosine or its 
metabolites (Barber and Butcher, 1983). Incubated 
whole ovaries (Selstam et al., 1976a), perfused 
ovaries (Selstam et al., 1976b), incubated follicles 
(Nilsson et al., 1974), corpora lutea (Herlitz et 
al., 1974), isolated granulosa (Hamberger et al., 
1978) and luteal cells (Sender Baum and Ahrén, 
1986b) all released cAMP in response to hormonal 
stimulation. The physiological significance of the 
marked outflow of c AMP has remained an enigma 
(Barber and Butcher, 1983). 
In many tissues (Arch and Newsholme, 1978), 
including the ovary (Rosberg et al., 1975; Knecht 
and Catt, 1981), extracellular cAMP can be de­
graded by the ectoenzymes phosphodiesterase and 
5'-nucleotidase to AMP and adenosine. cAMP 
added to the medium increased granulosa cell 
ATP levels. The ATP increment was inhibited by 
DIP. Furthermore, a PDE inhibitor prevented 
cAMP from increasing ATP levels. This indicates 
that the ATP increase was dependent on PDE 
activity and nucleoside transport (see section 
Results and comments). Consequently, cAMP must 
have been degraded to AMP and adenosine, since 
cAMP and AMP are not transported into cells 
across intact plasma membranes (Barber and 
Butcher, 1983). In this context i t is also of inte rest 
to note that FSH stimulates both extra- and intra­
cellular PDE activity, thereby increasing both the 
cAMP production and its degradation to AMP 
within and between the ovarian cells (Selstam 
and Rosberg, 1976; Conti et al., 1984). The intracel­
lular PDE is stimulated by FSH with a lag-phase 
of about 1 h (Conti et al., 1984). Contradictory 
results have been reported suggesting that FSH 
inhibits extracellular PDE activity (Rnecht and 
Catt, 1981). However, réévaluation of the latter 
data suggest that, due to the experimental design, 
total adenosine metabolism was studied rather 
than extracellular PDE activity. 
Observations in isolated luteal tissue, similar 
to those mentioned above, have not been presented 
to my knowledge. However, ovarian PDE activity 
varies during the estrous cycle in the rat, the 
activity being increased during metestrus (Schmidtke 
et al., 1980). Also in the testis, FSH stimulates PDE 
activity (Conti et al., 1981,1982,1983). 
It could be concluded that cAMP is released 
in ovarian tissue and, subsequently degraded 
extracellularly to adenosine. Therefore, an adeno­
sine recirculation and reutilization may be proposed. 
Extracellular adenosine levels 
If t he above described mechanisms of adenosine 
formation from cAMP and decreasing levels of 
cellular ATP in ovarian tissue are correct, then 
a rough estimate could be made of the cellular 
contribution to extracellular adenosine. An ap­
proximate estimation (see section Appendix) reveals 
that the cAMP efflux, from FSH-stimulated cells 
in vitro could increase the concentration in the 
extracellular space in the follicular wall with as 
much as 4-5 |JLM every minute and this cAMP 
could be subject to metabolization to adenosine. 
Moreover, if the gonadotropin-induced decrease 
in cellular ATP results in egress of adenosine, as 
has been suggested for other cells (Arch and 
Newsholme, 1978), a considerable amount of ade no­
sine would be found in the extracellular space. 
The FSH-induced decrease of granulosa cell ATP 
levels would result in an adenosine outflow increas­
ing the extracellular concentration with 18-20 
I^M/min and in FSH-stimulated cumuli of 12-13 
|IM/min. Taking in account the estimated uptake 
of adenosine into granulosa cells (paper I) the 
FSH-stimulated efflux of cAMP/adenosine would 
theoretically result in an equilibrium of 1-6 |IM 
in the follicular wall after just minutes (for further 
details on assumptions and calculation see Appen­
dix). 
These calculations are mere estimations and 
resulting from the assumptions. The calculations 
are curtailed by the lack of knowledge, for in­
stance, of the local 5'-nucleotidase and PDE 
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activity, the difficulty in estimating cAMP efflux 
(Barber and Butcher, 1983), the activity of adeno­
sine deaminase, and the estimation of adenosine 
uptake kinetics. However, the estimations still 
support a plausible model that adenosine in ovarian 
tissue is of ovarian origin. The model also presents 
the possibility that extracellular concentrations 
of adenosine are regulated by the cellular activity 
and that the calculated concentrations of a deno­
sine are in the range of effective adenosine 
receptor activation. It may be concluded that 
there is a basis for a local modulation of o varian 
cell activity by adenosine. 
Thus, the adenosine concentrations in the follicle 
may be theoretically a few |xM. Much higher levels 
of purines have been reported in porcine folli­
cular fluid (1.41 mM hypoxanthine, Downs et al., 
1985) and in murine follicular fluid (0.35-0.70 mM 
adenosine, 2-4 mM hypoxanthine, Eppig et al 
1985). However, these values may be overestimations 
due to the sampling procedure and the lack of 
use of degradative enzyme inhibitors. In human 
follicular fluid collected during surgery and with 
prompt addition of ADA inhibitor, the values 
were much lower (0.3 |xM adenosine, 3.7 |i,M hypo­
xanthine, Billig and Fredholm, unpublished re­
sults) and in bovine follicular fluid no purines 
could be detected (Eppig and Downs, 1987). 
A m odel for para/autocrine action of a denosine 
in the ovary. 
The data presented and referred to on adenosine 
action in general and in ovarian cells in particular 
meet many of the requirements for a local and/or 
paracrine action and reveal that: 
- adenosine may be produced in and released from 
ovarian cells (i.e. the enzymes for adenosine 
formation are present in the same compartment 
as the substrate for adenosine formation) 
- adenosine may induce metabolic effects as a 
substrate (e.g. ATP increase, normalization of 
oxygen consumption, decreased lactate accumula­
tion, increased substrate availability to cAMP 
formation etc) 
- adenosine may induce metabolic effects as a 
receptor agonist (e.g. adenylate cyclase stimula­
tion, cAMP production) 
- adenosine production, release and uptake may 
be regulated within the ovary (i.e. regulation 
by gonadotropins) 
- adenosine concentrations in the extracellular 
space, deduced from theoretical calculations, 
are in the range for efficient uptake and 
receptor action and are not in conflict with 
estimated concentrations in other tissues 
If these circumstantial pieces of evidence 
(derived from incubation experiments) for modula­
tion of ovarian cell activity by adenosine prove 
to be correct, also in vivo, then they favour 
the adenosine receptor-mediated local regulation 
rather than regulation via adenosine substrate 
availability. The net increase in ATP and cAMP 
due only to adenosine as substrate would require 
a net increase of ovarian adenosine, and not a 
relocation of a constant, or decreasing, adenosine 
content from the intracellular to the extracel­
lular space in the ovarian compartments. Ade­
nosine receptor-mediated effects on cellular 
metabolism do not require a net increase in 
adenosine, but just a metabolically induced reloca­
tion of adenosine from within the cell to the 
extracellular space to increase receptor agonist 
interactions. 
This does not imply that adenosine as substrate 
is of no importance. Adenosine as a substrate 
seems to be a prerequisite for a number of cel­
lular events and not a regulatory factor like the 
receptor-mediated events. 
A speculative and simplified model for para­
crine/autocrine action in the ovary may be proposed 
based on the discussion above: The adenosine is 
of ovarian origin and gonadotropin stimulation 
induces a relocation of adenosine from within 
the cell to the extracellular space. The relocation 
is a result of a gonadotropin-induced decrease of 
cellular ATP levels and subsequent increase in 
AMP concentration (due to a relative decrease in 
the phosphorylation/dephosphorylation ratio of 
phosphorylated adenine nucleotides) and an in­
creased efflux of cAMP. The cAMP is degraded 
to AMP by PDE. Intra- and extracellular AMP is 
further degraded to adenosine. Extracellular 
adenosine bind to and activate adenosine A2 
receptors in an autocrine/paracrine manner. Adeno­
sine receptor activation augments the adenylate 
cyclase response to gonadotropin and its functional 
parameters and indirectly increases the adenosine 
(AMP/cAMP) outflow by a short loop feedback 
mechanism. Adenosine is also subject to uptake 
into cells. However, the uptake is diminished 
gonadotropin stimulated cells. 
If the gonadotropin-stimulation in every cell 
is not equal, e.g. if the receptor occupancy is dif­
ferent due to submaximal levels of hormones or 
the distribution of receptor is unequal in a group 
of cells (e.g. part of the corpus luteum, the follicle 
or the whole follicle), then the gonadotropin re­
sponse and adenosine uptake would be unequally 
distributed. The less gonadotropin-stimulated or 
the unstimulated cells would take up more adenosine 
than the stimulated ones. The less stimulated 
cells would then increase their ATP levels and 
be more responsive to a weak gonadotropin stimula 
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Fig 8 
A m odel for auto/paraorine action of adenosine in ovarian cells. Initiation of gonadotropin stimulation (open 
squares, left panel) with subsequent adenylate cyclase activation, decrease of cellular ATP, out flow of cAMP 
and adenosine (closed triangels). 
The left panel depicts the initiation of gonadotrophic stimulation of granulosa cells. The panels to the right 
depict events later on during stimulation. For further details see page 35. 
tion at a later stage. When the gonadotropin 
stimulation is terminated, the remaining augmented 
levels of extracellular adenosine are decreased by 
cellular uptake and adenosine receptor activation 
is decreased (fig 8). 
This theoretical model of dual adenosine action 
as substrate and receptor agonist in the ovary 
would imply that the gonadotropin response is 
more equally distributed in, for instance, the 
preovulatory follicle, than the gonadotropin receptor 
distribution would suggest (Amsterdam et al., 
1975; Uilenbroek and Richards, 1979). The model 
also delineates a possibility of prolonging the 
gonadotropin action when hormone levels fall, of 
mediating a faster response when h ormone levels 
rise, and of equalizing variations in gonadotropin 
stimulation due to pulsatility or restrains in 
diffusion of the hormone. 
Concluding remarks 
The presented study has not established a 
physiological regulating role for adenosine in 
ovarian function, but demonstrated potentiating 
effects of adenosine, both as substrate and as 
adenosine A2 receptor agonist, on ovarian cell 
metabolism. The results suggest a possible para­
crine/autocrine role for adenosine but do not 
estimate the relative importance of ad enosine as 
substrate and as adenosine receptor agonist in 
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relation to other regulatory endocrine or paracrine 
hormones in the ovary, such as gonadotropins, 
prostaglandins, steroids, growth factors etc. 
Moreover, if a number of questions regarding 
adenosine and its action have been clarified or 
become less obscure, initial questions remain and 
new have ap peared. Most of the m are unanswered 
and urging to be resolved. 
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APPENDIX 
Theoretical calculations on extracellular adenosine 
levels 
If the above described mechanis ms of adenosi ne 
formation from cAMP and decreasing levels of 
cellular ATP in ovarian tissue are correct, then 
it would be possible to make a rough estimation 
of the cellular contribution of extracellular adeno­
sine. However, a number of assumptions have to 
be made and the conclusions could of cours e not 
be more accurate than the assumptions (table 7). 
Let us assume t hat maximal FSH-stimulated cAMP 
formation and outflow are linear over 90 min and 
result in a net efflux of 10 pmol cAMP/10^ 
granulosa cells or 110 fmol cAMP/10^ cells/min 
(as in paper I). Furthermore, let us assume that 
the outflow of cAMP is of the same magnitude 
in the intact follicle in situ and that cAMP is 
degraded to adenosine. The extracellular space 
within the follicular wall is assumed to be as 
large as 30% of total volum e or 60% of the intracel­
lular volume, as in prepubertal ovaries (Nilsson 
and Selstam, 1975) and the granulosa cell dia­
meter is assumed to be 9 (im (Nordenström et al., 
1985). 
Based on these assumptions, not taking in 
account the time required for cAMP metaboliza-
tion in vitro, re-uptake of adenosine etc, the net 
increase of extracel lular cAMP/adenosine concentra­
tion would be 4-5 p,M per m inute. The chance 
for degradation of cAMP in the tissue must be 
greater than in dispersed cell incubations since 
the degrading enzymes are cell membrane-associated. 
If the same assumptions are made for the 
maximal FSH induced decrease in ATP levels in 
granulosa cells (approximately 40% or from 2.5 
mM to 1.5 mM cellular ATP, paper I) and the 
ATP decrease exclusively resulted in a proportional 
adenosine/AMP outflow, then the adenosine con­
centration in the extracellular space wou ld increase 
with 18-20 (jlM/10^ cells every minute if linear 
over 90 min. However, judging from the data in 
paper I the FSH-induced decrease in ATP levels 
seems to be much more prompt and sustained. 
Similar calculations- made for the FSH-induced 
ATP decrease in cumulus-oocyte complexes suggest 
that the addition of adeno sine within the cumulus 
cell mass would be 12-13 |j,M/cumulus per minute. 
The microenvironment surrounding the cells 
will be the immediate acceptor of the cell-derived 
adenosine. However, the adenosine will diffuse in 
the follicle. If the equilibrium v olume for adenosine , 
assumed to be derived from the FSH-induced 
decrease in ATP levels, would be the whole 
follicular volume then the increase in adenosine 
concentration would be 1-2 (xM/min. 
In this hypothetical model for extracellular 
adenosine effluxes the effect of ad enosine uptake 
has not been considered. The values for adeno­
sine kinetics presented in paper I (Km 16 (lM 
and Vmax 1.6 |j,M/min/105 cells) are used in the 
calculations. The cAMP outflow from granulosa 
cells, if p romptly converted to adenosine, would 
result in an equilibrium between release and uptake 
of a denosine irrespective of the size of the extra­
cellular space. The equilibrium concentration of 
adenosine is calculated to 1 p-M and reached with in 
one minute in an extracellular space of 30% of 
total volume. If the same assumptions and calcula­
tions are carried out for the gonadotropin-induced 
ATP decrease an equilibrium concentration of 6 
|iM will be reach ed within one minute (for further 
details see table 7). 
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Table 7 
Theoretical calculations on extracellular adenosine derived from follicular cells from gonadotropin Induced cAMP outflow and 
cellular ATP decrease 
Assumptions: 
cAMP outflow and cellular decrease In ATP Is reflected In a prompt and equlmolar Increase In adenosine 
gonadotropin Induced cAMP outflow In granulosa cells Is assumed to be linear over 90 mln 
10 pmol/105 cells/90 mln = 110 fmol/105 cells/mln (data from paper I) 
gonadotropin Induced decrease ATP level In granulosa cells Is assumed to be linear over 90 mln 
40 pmol/105 cells/90 mln = 440 fmol/105 cells/mln (data from paper I) 
granulosa cell diameter 9 p.m (Nordenström et al., 1985) 
granulosa cell volume of 105 cells (V^) 
Vce|| = (4rr/3) * (4.5)3 * 10"9 •= 0.03 8 pJ 
extracellular volume between cells (VEX) Is assumed to be 60% of cell volume (VQ.II) (Nilsson and Selstam, 1975) 
60% * 0.038 N-L = 0.023 PU 
Increase of extracellular adenosine concentration derived from cAMP outflow, not taking In account adenosine uptake: 
(cAMP efflux/piln) / (Vex) - FluxoAMp 
(110 fmol/105 cells/mln) / (0.023 |il) = 4.8 jiM/mln 
Increase of extracellular adenosine concentration derived from decreased ATP level, not taking Into account adenosine uptake: 
(ATP decrease/mln) / (Ve„) = FIUXATP 
(440 fmol/105 cells/min) f (0.023 ill) = 19.1 jtM/mln 
Effect of adenosine uptake with Mlchaells-Menten kinetics on time-dependent increase (Rux„^p and Rux^jp) of extracellular 
adenosine concentrations. The extracellular concentration of cAMP- and ATP-derlved adenosine (C) will be reach an equilibrium 
(Cmax) when th9 outflow equals the uptake, not taking In account adenosine degradation eto. The rate of gonadotropin-induced 
Increase in extracellular adenosine concentration (V(t)) Is described by: 
V(t) = Rux-(Vmax*C)/(Km + C) 
Km = 16 |iM Vmax = 1.6pmol/mln (data from paper I) 
When V(t) = 0 then Rux = (Vmax * CJ/fK^ + C) C » Cmax 
^'uxcAMP " ^ ux m (^max * C)/(Km + C) ^UXATP = (Vmax * C)/(Km + C) 
^max ~ t .2 p.M ^max ~ 
The Cmax will be reached Irrespective of the size of the extracellular space. However, the time required Is of course Increased 
with Increased equilibrium volume. With the extracellular volume used In the calculations above (Vex = 0.6 * VC0||), Cmax will be 
reached In approximately one minute. If the Vex Is Increased 10 times Cmax will be reached In approximately 10 minutes. 
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